interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
5925 |
6. Filter based on genotype QC (FinnGen only) |
5925 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Interstitial lung disease endpoints
based on the number of shared cases.
Similar with more cases:
- Other interstitial pulmonary diseases
- Interstitial lung disease
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
- Diseases of the respiratory system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 38350 | 16182 | 21649 |
| Only index persons | 27651 | 12043 | 15608 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.54 | 0.46 | 0.60 |
| Only index persons | 0.53 | 0.44 | 0.60 |
| Median age at first event (years) | |||
| Whole population | 71.02 | 71.12 | 70.96 |
| Only index persons | 70.42 | 69.93 | 70.79 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5925 | 2347 | 3578 |
| Unadjusted period prevalence (%) | 1.27 | 0.80 | 1.58 |
| Median age at first event (years) | 69.34 | 66.73 | 71.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5266
- Matched controls
- 52659
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
467
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
323.0
3455
18317
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
389
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.4
323.0
1892
3310
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.9
323.0
1827
2438
TGC00
NOMESCO Finland
Bronchial lavation
37.0
323.0
1178
406
XG410
NOMESCO Finland
Flow-volume spirometry
9.0
323.0
786
1006
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
20.5
323.0
994
590
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
8968.6
323.0
2518
5
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
13505.8
323.0
2752
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
323.0
1440
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
323.0
2636
10196
H02AB06
ATC
prednisolone; systemic
5.2
323.0
3854
18200
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
26.9
323.0
1795
991
L04AX05
ATC
pirfenidone; oral
+∞
321.1
305
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.9
316.9
1185
2939
R06.0
ICD-10 Finland
Dyspnoea
3.3
305.5
2143
9150
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.4
292.7
842
1519
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
9.6
262.4
565
649
L04AX01
ATC
azathioprine; systemic
8.2
251.2
595
801
R03AC02
ATC
salbutamol; inhalant
2.7
249.1
3125
18566
GD1AD
NOMESCO Finland
Thorax CT examination
6.6
237.1
655
1102
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
219.0
2332
12277
L01XE31
ATC
[U] nintedanib; oral
+∞
205.5
196
*
J96.1
ICD-10 Finland
Chronic respiratory failure
9.0
202.8
450
538
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
201.7
705
1566
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
201.5
817
2115
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
66.4
197.3
229
36
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
27.8
195.7
272
103
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.1
190.1
658
1441
L04AA06
ATC
mycophenolic acid; systemic
13.6
177.4
317
246
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
45.2
175.0
217
50
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
168.6
161
*
J01MA14
ATC
moxifloxacin; systemic
3.6
163.2
832
2604
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
161.4
914
3103
48499
ICD-8 Finland
Acute interstitial pneumonia
+∞
150.7
144
*
P01BA02
ATC
hydroxychloroquine; oral
3.9
147.7
683
1959
R03BB04
ATC
tiotropium bromide; inhalant
3.0
146.4
976
3698
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.7
144.8
537
1250
A02BC02
ATC
pantoprazole; systemic
2.2
141.9
3663
27103
L01EX09
ATC
nintedanib; oral
+∞
136.0
130
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.3
131.5
529
1330
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.3
121.6
342
574
R05
ICD-10 Finland
Cough
2.4
120.9
1245
6008
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
118.1
113
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
116.7
1194
5728
C03CA01
ATC
furosemide; systemic
2.0
116.5
2215
13992
M05BA04
ATC
alendronic acid; oral
3.1
116.2
720
2561
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.9
116.2
405
877
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
110.8
1162
5624
GDG10
NOMESCO Finland
Bilateral transplantation of lung
371.6
109.7
110
*
Z94.2
ICD-10 Finland
Lung transplant status
110.6
109.4
119
11
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
10.8
93.9
186
178
J01MA12
ATC
levofloxacin; systemic
2.1
90.7
1284
7035
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
90.1
1078
5486
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
89.8
889
4128
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
88.5
595
2212
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
434.6
86.3
86
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
85.9
1421
8261
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
85.3
300
652
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
11.5
85.1
163
146
J01AA02
ATC
doxycycline; systemic
1.9
83.2
4007
33172
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
82.0
690
2928
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
81.6
469
1564
J47
ICD-10 Finland
Bronchiectasis
5.8
79.8
237
424
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
78.9
540
2022
J43.9
ICD-10 Finland
Emphysema, unspecified
6.1
77.7
220
371
R4110
NOMESCO Finland
Physiotherapy
1.9
76.6
1521
9382
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
76.0
1208
6861
R02
ICPC
Shortness of breath/dyspnoea
2.3
75.5
790
3740
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
9.1
75.0
163
185
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
73.6
2397
17260
R03BA08
ATC
ciclesonide; inhalant
2.9
73.4
497
1846
R50.9
ICD-10 Finland
Fever, unspecified
2.2
72.8
861
4313
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
70.7
1097
6145
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
70.2
453
1630
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.9
69.4
307
830
L04AA13
ATC
leflunomide; oral
5.2
69.0
223
441
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
68.8
1261
7508
J01FA06
ATC
roxithromycin; oral
1.7
68.2
2057
14374
R03AK08
ATC
formoterol and beclometasone; inhalant
4.2
67.5
272
676
R04.2
ICD-10 Finland
Haemoptysis
3.5
65.7
329
985
XG466
NOMESCO Finland
Sleep oxymetry
3.9
65.5
286
764
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
65.4
1677
11123
WX892
NOMESCO Finland
Monitored bed care
2.5
65.1
561
2392
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
64.7
872
4599
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
64.6
1168
6899
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
62.8
1101
6418
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
61.9
456
1776
H02AB07
ATC
prednisone; oral
2.0
61.2
864
4632
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.8
60.1
90
44
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
59.9
481
1968
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
59.6
417
1575
XX4BW
NOMESCO Finland
NA
47.9
58.4
71
15
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.0
55.5
186
383
L04AD01
ATC
ciclosporin; systemic
5.4
55.4
173
329
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
55.1
950
5473
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.9
53.7
126
163
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
4.4
53.6
202
470
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
53.2
1421
9417
WW200
NOMESCO Finland
Immunization
4.1
53.1
219
556
J01CA04
ATC
amoxicillin; systemic
1.6
53.0
3782
32215
127
Kela drug reimbursment
Transplant complication
6.1
52.7
148
247
R03AK07
ATC
formoterol and budesonide; inhalant
1.9
52.5
914
5276
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.2
52.4
170
338
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.9
51.1
326
1158
R81
ICPC
Pneumonia
3.4
50.6
256
772
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.0
50.2
168
346
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
10.5
49.9
99
96
R28
ICPC
Limited function/disability (R)
5.9
49.3
143
249
ZX120
NOMESCO Finland
Intravenous
2.2
49.0
577
2849
R05
ICPC
Cough
1.8
48.5
1091
6833
ZX108
NOMESCO Finland
Inhalation
9.5
48.3
101
108
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.9
48.0
112
144
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.6
47.2
226
652
GX1K5
NOMESCO Finland
Diffusion capacity
30.3
47.1
63
21
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
17.0
46.3
74
44
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.4
46.0
172
398
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.4
45.5
232
703
N02AX02
ATC
tramadol; systemic, rectal
1.5
45.2
2190
16727
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
45.2
745
4199
R99
ICPC
Respiratory disease other
4.7
44.0
155
338
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
43.7
404
1775
R03BA02
ATC
budesonide; inhalant
1.8
42.2
850
5117
A02BC01
ATC
omeprazole; systemic
1.6
42.0
1510
10694
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
41.5
1557
11137
WX721
NOMESCO Finland
Oxygen concentrator therapy
22.9
40.9
59
26
J84
ICD-10 Finland
Other interstitial pulmonary diseases
144.4
40.8
43
*
A02BC05
ATC
esomeprazole; systemic
1.5
40.6
1940
14656
A07AA02
ATC
nystatin; oral
2.3
40.2
392
1768
C07AB07
ATC
bisoprolol; oral
1.5
39.8
2696
21902
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
39.6
694
3981
R03BA01
ATC
beclometasone; inhalant
1.8
39.3
726
4237
L88
ICPC
Rheumatoid/seropositive arthritis
3.1
39.2
227
756
I50.0
ICD-10 Finland
Congestive heart failure
2.0
39.2
561
2986
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
137.7
38.8
41
*
R03BA05
ATC
fluticasone; inhalant
1.7
37.6
839
5198
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.4
37.3
138
317
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.4
36.7
113
213
WZC30
NOMESCO Finland
Teaching
1.8
36.6
686
4020
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.8
36.6
162
439
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.5
36.1
177
521
R03DC03
ATC
montelukast; oral
1.8
36.1
671
3918
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
7.1
35.8
89
127
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
35.2
969
6361
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
35.1
549
3016
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
35.0
352
1610
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
35.0
1493
10909
GX1D5
NOMESCO Finland
Flow volume spirometry
43.3
35.0
43
10
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
34.9
2120
16684
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
34.8
626
3611
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
124.2
34.7
37
*
J01FA10
ATC
azithromycin; systemic
1.4
34.6
2304
18448
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
34.3
600
3429
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.1
34.2
419
2091
GDA10
NOMESCO Finland
Biopsy of lung
15.7
34.2
56
36
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
34.0
557
3111
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.5
33.9
123
277
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
33.6
514
2799
E0000UV
ATC
NA
1.5
33.2
1754
13381
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.9
32.9
76
97
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
21.0
32.6
48
23
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.4
32.5
166
505
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
32.5
32.2
42
13
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
32.1
259
1058
F1246
NOMESCO Finland
NA
20.6
31.7
47
23
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
31.5
391
1961
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
31.3
959
6453
L04AA01
ATC
[U] ciclosporin; systemic
4.4
31.2
115
264
J20
ICD-10 Finland
Acute bronchitis
2.0
31.1
446
2370
G47.3
ICD-10 Finland
Sleep apnoea
1.6
30.7
974
6607
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.9
30.7
131
345
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
30.6
268
1141
M34.1
ICD-10 Finland
CR(E)ST syndrome
12.0
30.6
56
47
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
30.5
374
1865
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
4.9
30.3
101
209
M05BA07
ATC
risedronic acid; oral
2.7
30.3
214
811
J43.8
ICD-10 Finland
Other emphysema
11.5
30.0
56
49
D07AC01
ATC
betamethasone; topical
1.4
29.8
1605
12222
J01FF01
ATC
clindamycin; systemic
1.5
29.5
1254
9090
JN4BD
NOMESCO Finland
Extensive body CT
1.7
29.4
634
3862
J94.1
ICD-10 Finland
Fibrothorax
37.2
29.3
37
10
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
12.8
29.3
52
41
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
6.8
28.8
73
108
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.9
28.8
66
84
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
28.6
367
1866
XX9XE
NOMESCO Finland
Other ultrasound examination
6.0
28.6
80
135
M01CB01
ATC
sodium aurothiomalate; parenteral
4.0
28.2
115
291
R06AE07
ATC
cetirizine; oral
1.4
28.1
1742
13593
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.9
27.9
117
304
XG460
NOMESCO Finland
Short time oxymetry
3.5
27.7
135
397
N02BE01
ATC
paracetamol; systemic, rectal
1.5
27.6
4203
38404
A03
ICPC
Fever
1.7
27.4
574
3466
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
27.3
338
1693
2AX04
NOMESCO Finland
NA
53.6
27.2
32
6
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
23.9
26.9
38
16
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.3
26.9
137
417
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
26.6
275
1273
WX726
NOMESCO Finland
High-flow oxygen therapy
24.8
26.5
37
15
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
26.4
530
3155
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
26.4
895
6143
J80
ICD-10 Finland
Adult respiratory distress syndrome
9.6
26.4
54
57
J01DB01
ATC
cefalexin; oral
1.4
26.3
3819
34353
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
6.6
26.2
68
104
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
8.5
25.9
57
68
L04AB01
ATC
etanercept; parenteral
4.9
25.5
85
177
J96.0
ICD-10 Finland
Acute respiratory failure
3.7
25.4
114
314
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
25.3
179
678
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
12.6
25.3
45
36
L04AB04
ATC
adalimumab; parenteral
4.4
25.1
93
216
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
+∞
25.0
24
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
12.3
25.0
45
37
R06.2
ICD-10 Finland
Wheezing
2.4
24.9
226
982
WX872
NOMESCO Finland
Intensive care
2.1
24.9
298
1473
M04AA01
ATC
allopurinol; systemic
1.6
24.8
810
5501
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
24.8
1259
9410
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
24.8
1436
11007
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.8
24.7
83
174
WX722
NOMESCO Finland
PEEP
2.1
24.7
276
1322
H02AB04
ATC
methylprednisolone; systemic
1.6
24.7
693
4533
RS123
NOMESCO Finland
NA
32.2
24.6
32
10
A02BC03
ATC
lansoprazole; oral
1.4
24.2
1445
11125
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
24.2
710
4696
F2680
NOMESCO Finland
NA
13.2
24.1
42
32
B01AA03
ATC
warfarin; systemic
1.4
24.0
1286
9698
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
24.0
234
1055
Z51.5
ICD-10 Finland
Palliative care
1.9
24.0
373
2037
J01FA15
ATC
telithromycin; oral
1.8
23.6
424
2433
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
23.4
1682
13365
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
23.4
418
2397
A01AB09
ATC
miconazole; local oral
1.8
23.3
444
2595
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
23.3
1918
15587
N03AX16
ATC
pregabalin; oral
1.5
23.2
1074
7864
XJC10
NOMESCO Finland
Oesophageal pH monitoring
6.7
23.1
59
89
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
22.9
685
4546
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.3
22.9
86
203
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
22.7
1388
10710
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.4
22.7
199
850
3A006
NOMESCO Finland
NA
230.9
22.6
23
*
J01FA09
ATC
clarithromycin; systemic
1.4
22.6
1237
9352
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
120.5
22.6
24
*
J99.0
ICD-10 Finland
Rheumatoid lung disease
120.5
22.6
24
*
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.1
22.3
124
405
XG405
NOMESCO Finland
Education on PEF monitoring
3.6
22.2
101
283
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
22.2
333
1796
L01AA01
ATC
cyclophosphamide; systemic
6.7
22.0
56
84
AN1
HP
Coronary angiography
1.5
21.9
732
4987
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
+∞
21.9
21
*
C01DA14
ATC
isosorbide mononitrate; oral
1.5
21.7
1017
7453
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.3
21.6
111
342
R03AC03
ATC
terbutaline; inhalant
1.6
21.5
589
3822
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
31.3
21.4
28
9
J45.8
ICD-10 Finland
Mixed asthma
2.5
21.1
168
684
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
21.0
751
5193
JN4AD
NOMESCO Finland
Body CT examination
1.8
21.0
411
2424
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
21.0
1536
12189
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
20.8
727
5003
SPAT1262
SPAT
Handing over of treatment supplies
1.5
20.7
938
6822
UJF32
NOMESCO Finland
Coloscopy
1.4
20.6
1275
9830
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
20.5
284
1488
J43.2
ICD-10 Finland
Centrilobular emphysema
7.8
20.5
47
61
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
20.2
295
1574
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
5.0
20.1
65
132
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
20.0
209
973
Z57.2
ICD-10 Finland
Occupational exposure to dust
7.1
20.0
49
70
RK320
NOMESCO Finland
NA
4.4
20.0
73
168
L04AA24
ATC
abatacept; parenteral
9.8
20.0
40
41
J12.8
ICD-10 Finland
Other viral pneumonia
5.4
20.0
60
112
SPAT1325
SPAT
Vaccination
1.3
20.0
1751
14273
GAA31
NOMESCO Finland
Thoracoscopy
7.7
20.0
46
60
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.1
19.7
240
1195
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
19.7
503
3200
N02AA05
ATC
oxycodone; systemic
1.5
19.7
789
5588
120
Kela drug reimbursment
Hypogammaglobulinaemia
16.4
19.6
31
19
R03AK11
ATC
formoterol and fluticasone; inhalant
2.8
19.6
129
471
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
19.3
1206
9293
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.4
19.3
93
274
M33.2
ICD-10 Finland
Polymyositis
11.7
19.2
35
30
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
8.0
19.2
43
54
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.9
19.0
302
1662
GD2SN
NOMESCO Finland
Lung ventilation SPECT
5.0
19.0
61
123
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.0
19.0
109
363
5AB14
NOMESCO Finland
NA
14.0
19.0
32
23
WX110
NOMESCO Finland
Local anesthesy
1.3
18.9
2888
25424
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.9
18.8
116
407
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
17.1
18.7
29
17
SPAT1263
SPAT
Sampling
1.3
18.5
1908
15878
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.5
18.4
87
253
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.1
18.3
71
174
M35.1
ICD-10 Finland
Other overlap syndromes
7.1
18.2
44
62
M33.1
ICD-10 Finland
Other dermatomyositis
21.8
18.1
26
12
J05AB11
ATC
valaciclovir; oral
1.6
18.0
548
3643
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
5.0
18.0
57
114
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
17.9
1172
9086
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.1
17.9
100
329
R03BB01
ATC
ipratropium bromide; inhalant
1.9
17.9
259
1378
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.5
17.9
63
141
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
5.9
17.8
49
83
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
17.7
295
1651
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.6
17.7
129
499
R03AC12
ATC
salmeterol; inhalant
1.9
17.7
247
1296
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
17.7
204
994
WX002
NOMESCO Finland
Sedation and analgesia
1.4
17.7
931
6944
ZXA10
NOMESCO Finland
Bilateral
1.4
17.6
900
6674
M34.0
ICD-10 Finland
Progressive systemic sclerosis
14.6
17.6
29
20
J67.0
ICD-10 Finland
Farmer lung
12.5
17.6
31
25
C03DA01
ATC
spironolactone; oral
1.5
17.5
576
3899
M05.1
ICD-10 Finland
Rheumatoid lung disease
180.5
17.5
18
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
180.5
17.5
18
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
5.0
17.4
55
110
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
4.5
17.3
61
137
J46
ICD-10 Finland
Status asthmaticus
2.5
17.2
138
567
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
10.4
17.1
33
32
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
17.1
522
3471
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
17.0
1268
10021
M10.9
ICD-10 Finland
Gout, unspecified
1.7
17.0
374
2282
XF402
NOMESCO Finland
ECG with work load test
1.5
17.0
564
3825
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.1
17.0
41
58
E000001
ATC
NA
1.4
17.0
844
6227
RK110
NOMESCO Finland
NA
4.3
16.9
63
149
D07AC13
ATC
mometasone; topical
1.4
16.9
1234
9723
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
16.9
415
2610
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
10.7
16.9
32
30
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.4
16.9
142
598
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.7
16.9
114
425
B02.9
ICD-10 Finland
Zoster without complication
1.8
16.8
283
1589
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
16.8
1281
10163
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.2
16.7
163
738
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
35.1
16.6
21
6
R01AD12
ATC
fluticasone furoate; nasal
1.4
16.6
966
7323
J18
ICD-10 Finland
Pneumonia, organism unspecified
4.3
16.6
61
143
J01MA02
ATC
ciprofloxacin; systemic
1.3
16.5
1893
15923
XPX04
NOMESCO Finland
Angioscopy
8.6
16.4
35
41
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
16.3
357
2175
C09AA05
ATC
ramipril; oral
1.3
16.3
1355
10883
GX2C5
NOMESCO Finland
Short-lasting oximetry
14.3
16.3
27
19
J01DA01
ATC
[U] cefalexin; systemic
1.3
16.2
2835
25158
N02AA01
ATC
morphine; systemic, rectal
3.0
16.2
94
318
M05BX04
ATC
denosumab; parenteral
1.9
16.2
253
1387
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.4
16.1
136
572
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
16.1
381
2372
XQ800
NOMESCO Finland
Prick test
1.9
16.1
242
1306
R29
ICPC
Respiratory symptom/complaint other
1.9
16.1
256
1412
R01AD09
ATC
mometasone; nasal
1.3
16.0
1660
13750
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.3
16.0
42
67
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
16.0
322
1917
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.0
16.0
63
158
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
15.8
493
3292
R03DA04
ATC
theophylline; systemic, rectal
1.7
15.7
321
1916
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.5
15.7
512
3458
AK3
HP
BLTX (both lung transplants)
+∞
15.6
15
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
15.5
59
143
M25.5
ICD-10 Finland
Pain in joint
1.4
15.5
1052
8177
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
15.5
630
4459
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
15.5
1032
7999
I73.0
ICD-10 Finland
Raynaud syndrome
3.4
15.5
75
224
SPAT1255
SPAT
Intravenous administration of medicine
1.7
15.5
312
1858
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.5
15.4
123
505
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
15.3
365
2278
WX882
NOMESCO Finland
High dependency care
2.3
15.3
145
648
N03AX12
ATC
gabapentin; oral
1.5
15.0
642
4589
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
15.0
245
1361
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
15.0
1371
11141
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.8
15.0
62
163
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.4
14.9
131
563
N05CF01
ATC
zopiclone; oral
1.3
14.9
1549
12815
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.7
14.8
50
108
D07AB08
ATC
desonide; topical
1.6
14.8
439
2899
A28
ICPC
Limited function/disability NOS
1.4
14.5
828
6241
TGD00
NOMESCO Finland
Needle biopsy of lung
5.3
14.5
43
81
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
10.8
14.5
27
25
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.3
14.4
134
594
R03AC13
ATC
formoterol; inhalant
1.8
14.4
236
1312
R4190
NOMESCO Finland
Nutritional therapy
2.3
14.4
137
615
318
Kela drug reimbursment
Teriparatide
5.6
14.3
41
74
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
11.4
14.2
26
23
R01AD08
ATC
fluticasone; nasal
1.3
14.0
1031
8099
1240
FHL
Bronchoscopy
2.9
14.0
83
287
R05FB02
ATC
cough suppressants and expectorants
1.3
13.9
1713
14450
J96.9
ICD-10 Finland
Respiratory failure, unspecified
4.3
13.9
51
120
ZXA00
NOMESCO Finland
Right side
1.3
13.9
1310
10666
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
12.7
13.9
24
19
J02AC01
ATC
fluconazole; systemic
1.3
13.8
1346
11013
GX2D5
NOMESCO Finland
Sleep oximetry
7.8
13.8
31
40
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
4.7
13.7
46
99
5BA08
NOMESCO Finland
NA
4.5
13.7
48
108
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
13.7
368
2369
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.5
13.7
47
104
J98.4
ICD-10 Finland
Other disorders of lung
9.1
13.7
28
31
1CX01
NOMESCO Finland
NA
9.7
13.7
27
28
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.1
13.7
74
241
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
13.6
461
3133
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.6
1907
16335
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.8
13.6
225
1257
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
13.6
144
680
1XC02
NOMESCO Finland
NA
4.0
13.5
53
133
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.0
13.5
162
804
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
13.5
323
2017
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.8
13.5
239
1368
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
13.4
297
1815
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
13.3
353
2265
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
13.3
214
1185
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
13.3
236
1348
B01AB05
ATC
enoxaparin; parenteral
1.3
13.3
1398
11539
J93.8
ICD-10 Finland
Other pneumothorax
5.0
13.3
42
85
4040
NOMESCO Finland
NA
21.2
13.3
19
9
M31.3
ICD-10 Finland
Wegener granulomatosis
6.2
13.3
35
57
L04AC07
ATC
tocilizumab; parenteral
11.5
13.3
24
21
D07XC01
ATC
betamethasone, combinations; topical
1.5
13.3
534
3768
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
13.2
372
2423
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
13.2
197
1064
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
12.1
13.1
23
19
M79.6
ICD-10 Finland
Pain in limb
1.3
13.0
1458
12135
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
13.0
536
3805
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
28.4
12.9
17
6
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
19.1
12.9
19
10
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.2
12.9
66
207
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.9
1377
11386
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.5
12.9
58
165
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
50.1
12.8
15
*
H05AA02
ATC
teriparatide; parenteral
5.6
12.6
36
65
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
70.0
12.6
14
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
70.0
12.6
14
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
12.6
393
2624
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
17.3
12.5
19
11
J05AB01
ATC
aciclovir; systemic
1.4
12.5
807
6203
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
12.5
345
2239
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
12.5
278
1704
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
12.5
175
925
291
Kela drug reimbursment
Tofacitinib
10.0
12.4
24
24
J02AC03
ATC
voriconazole; systemic
9.3
12.4
25
27
J42
ICD-10 Finland
Unspecified chronic bronchitis
2.9
12.4
75
264
M01CB03
ATC
auranofin; oral
3.9
12.4
49
125
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
12.4
845
6551
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
12.3
1431
11948
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
9.6
12.2
24
25
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
9.6
12.2
24
25
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
12.2
280
1731
81
HP
Angiography of the heart and coronary arteries
1.5
12.2
410
2785
A46
ICD-10 Finland
Erysipelas
1.4
12.1
675
5056
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.3
12.1
111
492
R24
ICPC
Haemoptysis
4.3
12.0
43
100
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
9.3
12.0
24
26
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
11.8
168
894
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
11.8
1377
11492
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.6
11.8
51
141
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.4
11.8
41
93
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.9
11.7
69
239
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.5
11.7
53
152
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
9.6
11.7
23
24
Z31.5
ICD-10 Finland
Genetic counselling
2.1
11.7
125
593
J45
ICD-10 Finland
Asthma
1.5
11.7
362
2414
H02AB09
ATC
hydrocortisone; systemic
2.4
11.5
100
429
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
6.5
11.5
29
45
NDG30
NOMESCO Finland
Fusion of wrist, total
5.3
11.4
34
65
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
120.2
11.4
12
*
A02BA02
ATC
ranitidine; systemic
1.3
11.4
941
7500
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
4.0
11.3
44
111
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
11.3
1355
11332
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
5.8
11.3
31
54
J01GB01
ATC
tobramycin; inhalant, parenteral
15.0
11.3
18
12
M05BA06
ATC
ibandronic acid; systemic
2.4
11.2
95
403
R74
ICPC
Upper respiratory infection acute
1.3
11.2
805
6283
M54.5
ICD-10 Finland
Low back pain
1.3
11.2
1244
10310
NG1DA
NOMESCO Finland
X-ray of knees
2.5
11.1
86
351
R4120
NOMESCO Finland
Occupational therapy
1.6
11.1
264
1651
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
11.0
91
383
ED1AA
NOMESCO Finland
Mandipular X-ray examination
4.4
11.0
38
86
WX740
NOMESCO Finland
Nitrogen oxide therapy
9.2
11.0
22
24
S97
ICPC
Chronic ulcer skin
1.6
10.9
269
1694
E000002
ATC
NA
1.5
10.9
394
2718
Z94.3
ICD-10 Finland
Heart and lungs transplant status
43.4
10.9
13
*
L04AA17
ATC
[U] adalimumab; parenteral
6.2
10.9
28
45
C10AA03
ATC
pravastatin; oral
1.5
10.9
373
2547
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.6
10.9
76
291
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.7
10.8
45
121
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
10.8
328
2179
I27.0
ICD-10 Finland
Primary pulmonary hypertension
6.5
10.8
27
42
SPAT1260
SPAT
Consultation of another employee
1.3
10.7
763
5941
WX402
NOMESCO Finland
General anaesthesia
1.4
10.7
598
4483
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
10.7
853
6758
RS230
NOMESCO Finland
NA
4.7
10.7
35
75
I50.1
ICD-10 Finland
Left ventricular failure
1.6
10.7
268
1696
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
21.5
10.7
15
7
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
10.7
168
927
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
7.5
10.6
24
32
R2110
NOMESCO Finland
Giving the first information
1.6
10.6
245
1518
304
Kela drug reimbursment
Dornase alfa
60.1
10.6
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
60.1
10.6
12
*
R03AC19
ATC
olodaterol; inhalant
4.5
10.6
36
80
A01AB04
ATC
amphotericin B; local oral
1.7
10.6
225
1363
ZXA05
NOMESCO Finland
Left side
1.3
10.6
1201
9965
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.6
10.6
35
76
N07BA03
ATC
varenicline; oral
1.9
10.5
153
823
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.9
10.4
62
217
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
110.2
10.4
11
*
51701
ICD-8 Finland
Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)
+∞
10.4
10
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
10.4
366
2511
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.8
10.4
66
241
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.2
10.3
104
484
R03BB07
ATC
umeclidinium bromide; inhalant
3.4
10.2
48
143
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
10.2
608
4608
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.4
10.2
23
31
J94.8
ICD-10 Finland
Other specified pleural conditions
2.2
10.1
96
432
WX720
NOMESCO Finland
Own respiration
1.8
10.1
161
894
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.8
10.0
41
109
L04AA29
ATC
tofacitinib; oral
8.4
10.0
21
25
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
10.0
364
2516
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
10.0
529
3925
E000003
ATC
NA
1.8
10.0
174
995
J98.2
ICD-10 Finland
Interstitial emphysema
14.6
10.0
16
11
ZX197
NOMESCO Finland
NA
14.6
10.0
16
11
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
10.0
115
566
6BA02
NOMESCO Finland
NA
7.2
10.0
23
32
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
9.9
98
451
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
9.9
1676
14527
D72.1
ICD-10 Finland
Eosinophilia
5.8
9.9
27
47
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
9.9
184
1073
L04AB06
ATC
golimumab; parenteral
4.7
9.9
32
68
TK800
NOMESCO Finland
Hemodialysis
2.1
9.9
103
486
H03AA01
ATC
levothyroxine sodium; systemic
1.3
9.9
895
7207
B01AC04
ATC
clopidogrel; oral
1.3
9.8
856
6856
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
12.2
9.8
17
14
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
5.0
9.8
30
60
S18
ICPC
Laceration/cut
1.2
9.8
1897
16669
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.8
605
4610
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.4
9.7
80
338
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
9.7
359
2492
SPAT1059
SPAT
Spirometry at the office
1.7
9.7
216
1327
J37.0
ICD-10 Finland
Chronic laryngitis
2.0
9.7
128
663
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.4
9.7
79
330
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.6
9.7
67
259
B59
ICD-10 Finland
Pneumocystosis
13.4
9.6
16
12
J01FA01
ATC
erythromycin; systemic
1.4
9.6
437
3154
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.3
9.6
90
403
H26.3
ICD-10 Finland
Drug-induced cataract
4.1
9.6
36
89
XX7LW
NOMESCO Finland
NA
7.8
9.6
21
27
L04AB05
ATC
certolizumab pegol; parenteral
6.8
9.6
23
34
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.4
9.6
79
335
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
3.7
9.6
40
109
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
11.4
9.5
17
15
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
2.6
9.5
68
265
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
9.5
325
2219
L01CB
ATC
Podophyllotoxin derivatives
6.0
9.5
25
42
M06
ICD-10 Finland
Other rheumatoid arthritis
3.8
9.5
38
100
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
6.6
9.4
23
35
FXE00
NOMESCO Finland
Use of ECLA
30.0
9.4
12
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
30.0
9.4
12
*
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
9.4
9
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
9.3
126
2126
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.5
9.3
71
289
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
9.3
702
5510
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.4
9.3
74
308
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.2
9.3
88
398
M01AB55
ATC
diclofenac, combinations; oral
1.5
9.3
306
2074
XX4AW
NOMESCO Finland
NA
10.7
9.3
17
16
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
9.3
83
1563
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.6
9.2
66
257
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
9.2
321
2201
C08CA05
ATC
nifedipine; systemic
1.5
9.2
331
2284
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.3
9.2
44
134
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.9
9.2
36
93
L95
ICPC
Osteoporosis
1.9
9.2
130
692
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.6
9.2
39
108
N06AX11
ATC
mirtazapine; oral
1.2
9.2
1251
10579
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
9.0
1047
8691
A02BA03
ATC
famotidine; systemic
1.6
9.0
201
1239
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
9.0
225
1428
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
3.9
9.0
35
90
A04
ICPC
Weakness/tiredness general
1.4
9.0
528
3987
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
9.0
168
983
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
9.0
256
1678
L03
ICPC
Low back symptom/complaint
1.3
9.0
899
7329
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
8.9
411
2975
P01AB01
ATC
metronidazole; oral, rectal
1.2
8.9
1496
12933
XA421
NOMESCO Finland
Nocturnal polygraphy
5.2
8.9
26
50
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
8.9
151
858
132
Kela drug reimbursment
Sarcoidosis
3.3
8.9
42
127
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.1
8.9
93
442
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
8.8
286
1928
R04.0
ICD-10 Finland
Epistaxis
1.5
8.8
349
2453
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.4
8.8
69
286
RS221
NOMESCO Finland
NA
2.5
8.8
65
261
WX730
NOMESCO Finland
Conventional respirator
2.3
8.8
77
337
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
10.7
8.8
16
15
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
8.8
64
255
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.0
8.7
108
548
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
8.7
495
3721
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
50.1
8.7
10
*
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.5
8.7
275
1846
ZX140
NOMESCO Finland
Intra articular
3.4
8.6
40
119
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
8.6
226
1449
-1
NOMESCO Finland
NA
1.2
8.6
1120
9411
RK250
NOMESCO Finland
NA
3.7
8.6
35
94
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.7
8.6
35
94
AA1AD
NOMESCO Finland
CT of head and brain
1.2
8.6
1124
9456
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.7
8.6
166
982
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
8.6
139
779
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.3
8.6
40
120
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
8.5
196
1217
293
Kela drug reimbursment
Baricitinib
9.0
8.5
17
19
XF622
NOMESCO Finland
Measurement of minute volume of heart
4.9
8.5
26
53
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
27.5
8.5
11
*
J01XB01
ATC
colistin; inhalant, parenteral
20.0
8.5
12
6
ZX121
NOMESCO Finland
Central venous catheter
5.1
8.4
25
49
L04AA11
ATC
[U] etanercept; parenteral
5.1
8.4
25
49
R06AX27
ATC
desloratadine; oral
1.3
8.4
792
6400
RS220
NOMESCO Finland
NA
2.6
8.4
58
223
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
8.4
134
746
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
8.4
444
3292
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
6.0
8.4
22
37
D02AE01
ATC
carbamide; topical
1.5
8.4
259
1730
4038
NOMESCO Finland
NA
90.2
8.4
9
*
XF404
NOMESCO Finland
Ambulatory ECG
1.4
8.4
429
3164
5168X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies
+∞
8.3
8
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
8.3
253
1683
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
8.3
129
712
R63.4
ICD-10 Finland
Abnormal weight loss
1.7
8.3
155
910
RK310
NOMESCO Finland
NA
9.4
8.3
16
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
8.2
1162
9844
UDC00
NOMESCO Finland
Ear microscopy
1.5
8.2
293
2017
M02AA07
ATC
piroxicam; topical
1.2
8.2
1611
14117
R60.0
ICD-10 Finland
Localized oedema
1.4
8.1
493
3740
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
8.1
308
2151
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.0
8.1
43
142
R95
ICPC
Chron obstructive pulmonary disease
1.8
8.1
139
795
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.4
8.1
63
260
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.4
8.1
67
287
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
33.4
8.1
10
*
3006
Kela drug reimbursment
Baricitinib
8.1
8.1
17
21
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
17.2
8.1
12
7
C02KX04
ATC
macitentan; oral
11.7
8.1
14
12
ZX100
NOMESCO Finland
Oral
2.3
8.0
72
320
D07AA02
ATC
hydrocortisone; topical
1.4
8.0
477
3608
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
3.3
8.0
38
116
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
5.0
8.0
24
48
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
5.2
8.0
23
44
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
7.9
158
943
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
3.7
7.9
32
86
TNG10
NOMESCO Finland
Puncture of knee
2.7
7.9
52
197
N06AA09
ATC
amitriptyline; systemic
1.4
7.9
403
2976
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
7.7
7.9
17
22
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.4
7.8
35
102
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.5
7.8
26
58
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.9
7.8
107
566
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
7.8
363
2636
L04AA37
ATC
baricitinib; oral
8.4
7.8
16
19
A91
ICPC
Abnormal result investigation NOS
1.6
7.8
174
1076
M01AH02
ATC
rofecoxib; oral
1.3
7.8
574
4492
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
4.8
7.7
24
50
R76.0
ICD-10 Finland
Raised antibody titre
6.3
7.7
19
30
NDG74
NOMESCO Finland
Fusion of first IP joint
5.5
7.7
21
38
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
7.6
345
4603
D07AD01
ATC
clobetasol; topical
1.3
7.6
582
4573
R03BB06
ATC
glycopyrronium bromide; inhalant
3.5
7.6
33
94
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
7.6
1632
14398
3AC01
NOMESCO Finland
NA
2.6
7.6
51
196
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
18.4
7.6
11
6
C02KX01
ATC
bosentan; oral
11.8
7.6
13
11
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
7.5
354
2576
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
7.5
328
4403
5823
FHL
Lung avobiopsy and wedge resection
8.8
7.5
15
17
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
7.5
428
3218
R03BB05
ATC
aclidinium bromide; inhalant
4.3
7.5
26
61
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
1.9
7.5
105
563
HA1AA
NOMESCO Finland
X-ray mammography
1.5
7.5
227
1512
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.5
427
3213
B01AB04
ATC
dalteparin; parenteral
1.5
7.5
216
1422
XX1VW
NOMESCO Finland
Written report from radiologist
3.2
7.4
36
112
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
7.4
90
457
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
7.4
158
965
ZX114
NOMESCO Finland
Intramuscular
2.3
7.4
65
288
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
7.4
184
1169
S22.3
ICD-10 Finland
Fracture of rib
1.5
7.4
274
1908
F2682
NOMESCO Finland
NA
7.6
7.4
16
21
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.4
1028
8693
R06AX22
ATC
ebastine; oral
1.3
7.3
527
4107
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.4
7.3
59
251
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
+∞
7.3
7
*
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
9.4
7.3
14
15
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
7.2
918
7680
C08CA02
ATC
felodipine; oral
1.3
7.2
467
3580
A07EC02
ATC
mesalazine; oral, rectal
1.6
7.2
184
1174
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
2.9
7.2
42
147
WX723
NOMESCO Finland
CPAP therapy
1.8
7.2
114
635
SBA00
NOMESCO Finland
Microbiological examinations
1.9
7.2
94
489
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
15.7
7.2
11
7
T90
ICPC
Diabetes non-insulin dependent
1.2
7.2
1053
8940
R53
ICD-10 Finland
Malaise and fatigue
1.2
7.2
852
7073
J01DA06
ATC
[U] cefuroxime; systemic
1.3
7.2
543
4257
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.2
846
7016
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.9
7.2
42
148
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
7.2
37
121
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
7.2
177
1123
L17
ICPC
Foot/toe symptom/complaint
1.2
7.2
1005
8497
J93.9
ICD-10 Finland
Pneumothorax, unspecified
3.5
7.2
31
89
I50
ICD-10 Finland
Heart failure
1.6
7.1
169
1061
SBA10
NOMESCO Finland
Measurement of excretion of saliva
2.7
7.1
46
172
S29
ICPC
Skin symptom/complaint other
1.3
7.1
672
5432
M48.0
ICD-10 Finland
Spinal stenosis
1.3
7.1
570
4510
K07
ICPC
Swollen ankles/oedema
1.5
7.1
197
1288
R96
ICPC
Asthma
1.4
7.1
323
2338
F03
ICD-10 Finland
Unspecified dementia
0.6
7.1
88
1511
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.2
7.1
68
314
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.5
7.1
50
198
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
7.0
193
1256
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
8.8
7.0
14
16
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
7.0
148
901
3A064
NOMESCO Finland
NA
3.7
7.0
28
75
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.5
7.0
217
1451
L57.0
ICD-10 Finland
Actinic keratosis
1.3
7.0
486
3768
J01DA08
ATC
[U] cefaclor; oral
1.4
7.0
286
2030
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.0
1008
8549
R13
ICD-10 Finland
Dysphagia
1.4
7.0
270
1894
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
7.0
186
1205
M60.9
ICD-10 Finland
Myositis, unspecified
3.6
6.9
29
81
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
3.8
6.9
27
71
SPAT1060
SPAT
Administration of oxygen
3.7
6.9
28
76
J32.4
ICD-10 Finland
Chronic pansinusitis
2.5
6.9
52
211
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.7
6.9
121
699
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
6.9
46
177
M10
ICD-10 Finland
Gout
1.5
6.9
205
1360
SPAT1310
SPAT
Counselling related to known health issue
1.2
6.9
1300
11318
N06DA03
ATC
rivastigmine; oral, transdermal
0.5
6.9
70
1267
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.9
6.9
89
463
N06DA02
ATC
donepezil; oral
0.6
6.8
129
2013
WX204
NOMESCO Finland
Axillary plexus blockaced
1.8
6.8
109
611
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.5
6.8
49
196
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
6.8
325
2373
WW500
NOMESCO Finland
Blood transfusion
1.6
6.8
172
1098
A06AD11
ATC
lactulose; oral
1.3
6.8
708
5787
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.8
1315
11468
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.6
6.8
167
1059
3005
Kela drug reimbursment
Tofacitinib
6.7
6.8
16
24
J86.9
ICD-10 Finland
Pyothorax without fistula
2.5
6.8
49
197
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.7
6.8
44
165
602
Kela drug reimbursment
Children's severe malnutrition
10.9
6.8
12
11
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
5.0
6.8
20
40
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.4
6.8
30
88
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
6.8
108
603
L01BB01
ATC
NA
5.3
6.8
19
36
C01AA05
ATC
digoxin; systemic
1.3
6.7
459
3546
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
16.7
6.7
10
6
207
Kela drug reimbursment
Chronic arrhythmias
1.2
6.7
764
6308
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.2
6.7
63
288
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.5
6.7
29
84
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.1
6.7
72
349
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.6
1645
14654
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.4
6.6
295
2127
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.8
6.6
111
633
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.6
6.6
170
1093
J43.1
ICD-10 Finland
Panlobular emphysema
7.8
6.6
14
18
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.6
2308
21137
A02BA04
ATC
nizatidine; systemic
1.4
6.6
356
2656
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.4
6.6
29
85
-44
ICPC
Preventive immunization/medic
1.4
6.6
369
2771
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
12.2
6.6
11
9
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.6
114
657
XJC00
NOMESCO Finland
Oesophageal manometry
4.0
6.6
24
60
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.3
6.6
54
233
B01AF02
ATC
apixaban; oral
1.3
6.5
473
3687
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
6.5
217
1480
D11
ICPC
Diarrhoea
1.4
6.5
324
2387
DHA10
NOMESCO Finland
Biopsy of cavity of nose
2.8
6.5
38
135
A11
ICPC
Chest pain NOS
1.4
6.5
301
2189
WVA20
NOMESCO Finland
Medicine administration
1.9
6.5
94
510
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
6.5
1623
14471
TEA00
NOMESCO Finland
Biopsy of lip
2.8
6.5
39
142
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.6
6.4
43
166
M01CC01
ATC
penicillamine; oral
5.7
6.4
17
30
UGC08
NOMESCO Finland
Rigid bronchoscopy with biopsy of lung
69.9
6.4
7
*
N06DX01
ATC
memantine; oral
0.7
6.4
166
2429
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.4
2630
24359
NXL00
NOMESCO Finland
Biopsy of muscle
4.2
6.4
22
52
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
14.3
6.4
10
7
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.4
1628
14531
UJD02
NOMESCO Finland
Gastroscopy
1.5
6.4
208
1410
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.3
6.4
55
242
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
6.4
474
3709
I26
ICD-10 Finland
Pulmonary embolism
2.6
6.4
42
161
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
6.3
451
3507
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.4
6.3
47
193
L08
ICPC
Shoulder symptom/complaint
1.2
6.3
724
5981
J92
ICD-10 Finland
Pleural plaque
6.5
6.3
15
23
L03AA02
ATC
filgrastim; parenteral
1.8
6.3
106
604
I20.09
ICD-10 Finland
Unstable angina
1.4
6.3
285
2063
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.8
6.3
97
540
R01AD01
ATC
beclometasone; nasal
1.3
6.3
517
4101
XG430
NOMESCO Finland
Spiroegometry
11.0
6.3
11
10
49099
ICD-8 Finland
Bronchitis, unspecified
2.5
6.3
45
180
S22.2
ICD-10 Finland
Fracture of sternum
3.1
6.3
32
105
L28
ICPC
Limited function/disability (L)
1.2
6.3
725
5996
M33
ICD-10 Finland
Dermatopolymyositis
+∞
6.2
6
*
6BB16
NOMESCO Finland
NA
+∞
6.2
6
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
6.2
560
4495
XV5WT
NOMESCO Finland
NA
26.7
6.2
8
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
6.2
2774
25831
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
4.3
6.2
21
49
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
4.3
6.2
21
49
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
6.2
994
8507
J98.6
ICD-10 Finland
Disorders of diaphragm
3.4
6.2
27
79
K76.9
ICD-10 Finland
Liver disease, unspecified
2.2
6.2
56
251
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.4
6.2
261
1866
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
2.5
6.2
44
175
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
6.1
139
865
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.1
6.1
64
308
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
6.1
22
565
R03AC18
ATC
indacaterol; inhalant
2.5
6.1
45
184
N19
ICD-10 Finland
Unspecified kidney failure
1.5
6.1
169
1106
ECB20
NOMESCO Finland
Oral alveoplasty
2.5
6.1
42
166
B34.9
ICD-10 Finland
Viral infection, unspecified
1.9
6.1
77
400
WNF00
NOMESCO Finland
Infection source and contact determination
3.2
6.1
29
91
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
4.0
6.1
22
55
P70
ICPC
Dementia
0.4
6.1
26
621
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.1
6.1
63
302
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
6.0
201
1370
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.7
6.0
37
137
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
6.7
6.0
14
21
1243
FHL
Bronchoscopy and other therapeutic procedure
6.7
6.0
14
21
R04
ICPC
Breathing problem other
1.7
6.0
123
746
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1668
6451
3.21
321.01
9.1
6.8
kpa
5.0
5.1
0.80
1603
6120
(3027801) Oxygen [Partial pressure] in Arterial blood
1666
6449
3.20
320.02
9.1
6.8
kpa
10.2
12.1
59.14
1604
6114
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
787
1835
4.79
315.38
1.8
1.8
u/l
38.4
38.3
0.07
716
1562
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
615
1158
5.81
314.73
1.8
1.4
g/l
0.2
0.2
2.91
590
1091
(3003396) Base excess in Arterial blood by calculation
1651
6431
3.17
312.92
9.2
6.8
mmol/l
1.4
1.1
2.72
1370
4942
(3000492) Spirometry study
1219
3694
3.90
307.65
2.9
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
687
1226
6.21
307.65
2.4
2.2
g/l
128.7
127.4
0.35
269
929
(3013650) Neutrophils [#/volume] in Blood by Automated count
4424
27267
3.46
307.65
15.5
8.6
e9/l
4.7
4.3
28.25
4105
23577
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
562
711
8.63
307.65
1.5
1.3
—
—
—
0
0
(44790047)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
704
860
9.16
307.65
2.4
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
863
1418
6.95
307.65
1.3
1.2
u/ml
2.0
0.8
1.19
85
134
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
624
933
7.36
307.65
1.4
1.2
u/ml
7.8
3.2
0.74
92
83
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
710
648
12.31
307.65
2.1
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
742
292
28.91
307.65
2.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
552
652
9.23
307.65
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
637
620
11.39
307.65
2.7
2.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
987
1572
7.33
307.65
1.8
1.5
titre
279.5
230.8
0.25
64
76
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
685
797
9.59
307.65
1.2
1.2
u/ml
45.6
0.6
—
24
6
(3019060) Gas panel - Arterial blood
1293
3755
4.13
307.65
4.8
4.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
828
793
11.98
307.65
2.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1990
6703
3.96
307.65
1.4
1.3
iu/ml
57.3
36.6
4.31
698
2028
(44806118)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
544
561
10.58
307.65
2.6
1.5
—
—
—
0
0
(44790048)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4088
22014
3.76
307.65
12.4
5.7
%
2.7
2.9
4.63
3997
20307
(44790049)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
781
1299
6.77
307.65
1.7
1.4
iu/ml
11.4
17.2
0.56
33
29
(3018010) Neutrophils/100 leukocytes in Blood
4052
22167
3.62
307.65
12.1
5.7
%
60.5
58.4
23.24
3958
20475
(3005719) IgG [Mass/volume] in Serum or Plasma
1298
3279
4.79
307.65
4.1
2.6
g/l
10.3
10.5
0.67
1237
2960
(3022096) Basophils/100 leukocytes in Blood
4056
21424
3.83
307.65
12.3
5.7
%
0.6
0.7
2.95
3973
19782
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
616
716
9.49
307.65
1.8
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
589
736
8.78
307.65
3.0
2.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2177
9143
3.18
307.65
2.8
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4393
24224
4.15
307.65
12.4
5.6
e9/l
0.2
0.2
2.50
4065
20860
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1333
2001
8.31
307.65
1.6
1.6
u/ml
16.8
17.3
0.02
30
54
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
638
1006
6.99
307.65
1.4
1.2
u/ml
41.3
46.7
0.14
35
52
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
611
948
7.07
307.65
1.4
1.2
titre
177.3
141.2
0.11
22
17
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1724
6284
3.46
307.65
2.6
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
564
858
7.16
307.65
12.4
4.4
iu/ml
1522.1
2324.4
0.15
132
115
(42870588) Differential panel, method unspecified - Blood
3488
16503
3.71
307.65
11.4
5.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
4094
22123
3.75
307.65
12.9
6.1
%
8.9
8.9
0.01
4005
20468
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
749
1141
7.37
307.65
1.9
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
627
945
7.30
307.65
1.4
1.2
u/ml
12.8
6.3
1.21
140
145
(3037692) Legionella sp identified in Specimen by Organism specific culture
329
137
25.37
307.65
2.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1728
6264
3.48
307.65
2.6
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4341
23892
4.06
307.65
11.8
5.5
e9/l
1.9
1.9
0.05
4004
20610
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
443
167
28.59
307.65
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
4323
23343
4.15
307.65
11.7
5.4
e9/l
0.7
0.6
21.20
3952
19799
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
598
675
9.74
307.65
2.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
879
1108
9.14
307.65
2.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
2242
5241
6.27
307.65
1.5
1.3
titre
602.8
502.3
1.55
679
1108
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1838
6297
3.78
307.65
1.3
1.2
u/ml
29.2
13.2
2.68
534
2285
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
582
774
8.23
307.65
1.3
1.2
u/ml
19.4
2.4
1.82
56
55
(4010399)
1144
3286
4.08
307.65
2.0
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4099
22534
3.66
307.65
12.7
5.9
%
24.5
26.3
21.10
4006
20703
(3006315) Basophils [#/volume] in Blood
4332
23484
4.14
307.65
11.7
5.4
e9/l
0.0
0.0
5.71
3968
19953
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
583
631
10.14
307.65
1.8
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
892
1161
8.87
307.65
2.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
1014
2588
4.52
307.65
2.2
1.9
g/l
1.1
1.4
3.31
941
2301
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1302
1859
8.69
307.65
3.2
2.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1046
1121
11.12
307.65
1.9
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
618
1199
5.64
306.01
1.8
1.4
g/l
1.2
1.2
1.14
596
1126
(3005322) IgE [Units/volume] in Serum or Plasma
869
2254
4.35
303.66
1.6
1.2
u/ml
254.2
234.8
0.24
809
2043
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
415
540
8.19
301.48
3.5
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1413
5368
3.14
275.70
2.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2835
15526
2.58
272.19
6.1
4.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
209
107
20.21
271.68
1.3
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
311
332
9.83
263.81
2.0
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1174
4137
3.29
258.58
5.8
3.9
%
0.8
1.0
1.06
428
1251
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
287
286
10.49
255.83
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
286
284
10.53
255.57
2.1
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1083
3737
3.32
246.00
5.6
3.7
%
0.5
0.7
1.14
336
888
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
539
1125
5.17
244.59
1.8
1.9
mg/l
10.8
12.5
2.07
506
1026
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
149
39
39.16
243.66
3.1
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
323
429
7.91
229.90
2.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1040
3649
3.24
228.66
5.9
4.0
%
0.2
0.2
0.04
357
969
(3039162) Centromere protein B Ab [Units/volume] in Serum
324
441
7.71
225.74
1.3
1.2
u/ml
59.7
51.0
0.18
33
22
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3900
26091
2.45
224.92
10.0
6.1
umol/l
11.4
12.4
5.10
3787
24700
(3021440) Promyelocytes/100 leukocytes in Blood
1081
3931
3.14
223.35
5.9
3.9
%
0.1
0.1
1.17
398
1167
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
395
676
6.19
221.82
5.3
2.3
u/ml
694.4
2666.8
1.11
36
49
(3027135) IgG subclass 1 [Mass/volume] in Serum
298
377
8.27
220.92
1.4
1.3
g/l
7.7
6.7
2.18
204
257
(3024139) IgG subclass 3 [Mass/volume] in Serum
297
377
8.24
219.56
1.4
1.3
g/l
0.5
0.4
2.27
205
260
(3028192) IgG subclass 2 [Mass/volume] in Serum
297
377
8.24
219.56
1.4
1.3
g/l
3.0
2.9
0.29
207
260
(3016502) Oxygen saturation in Arterial blood
1388
5850
2.79
218.92
10.1
7.0
%
93.7
95.5
16.82
1344
5616
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
889
2907
3.42
218.63
10.8
8.8
mmol/l
24.6
24.3
2.42
819
2687
(4062490)
297
379
8.20
218.58
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
396
700
5.99
215.04
1.4
1.2
u/ml
60.4
46.0
0.75
61
64
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
320
455
7.38
214.40
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1217
4847
2.90
213.01
1.5
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
327
486
7.06
210.39
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
326
486
7.04
209.14
2.0
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3605
23729
2.33
209.12
9.6
6.1
mmol/l
1.2
1.2
4.77
3392
21304
(3024980) IgG subclass 4 [Mass/volume] in Serum
369
626
6.22
208.90
1.6
1.6
g/l
0.9
0.9
0.05
266
471
(3018418) pH of Serum or Plasma
2652
15427
2.30
205.92
5.6
4.0
ph
7.4
7.4
1.12
633
2912
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2859
17250
2.27
202.21
4.2
3.2
ng/l
1820.0
1801.8
0.06
2588
14992
(40760892) CBC W Ordered Manual Differential panel - Blood
1860
9398
2.43
198.77
8.9
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
433
892
5.16
198.67
4.6
3.6
%
59.6
58.3
1.05
433
892
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
251
304
8.58
192.65
1.3
1.1
u/ml
29.1
3.1
1.37
19
17
(3021589) Normoblasts [#/volume] in Blood
3204
20514
2.22
192.60
19.1
10.1
e9/l
0.0
0.0
0.69
2750
16625
(3042936) Bacteria identified in Isolate by Culture
1548
7292
2.52
191.84
2.6
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4636
34754
2.54
189.08
9.7
4.1
mm/h
18.4
13.9
54.39
4516
31677
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
255
324
8.18
188.14
1.3
1.1
u/ml
66.2
38.4
0.83
24
27
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
253
323
8.14
185.91
1.3
1.1
u/ml
65.8
82.7
—
9
15
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
234
273
8.88
185.01
4.2
3.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
256
334
7.97
184.69
1.3
1.1
u/ml
42.3
76.0
0.59
14
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3767
26165
2.21
178.97
10.5
6.8
mmol/l
1.2
1.2
1.45
3151
21935
(3007164) IgA [Mass/volume] in Serum or Plasma
1526
7542
2.38
167.00
1.9
1.5
g/l
2.8
2.6
2.57
1105
4344
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
710
2393
3.23
163.95
2.5
1.9
ug/l
2.3
2.7
0.20
646
2065
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
169
155
11.19
159.10
2.1
1.9
u/ml
61772.4
23010.6
0.26
22
22
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
348
767
4.76
146.76
1.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
867
3470
2.76
146.24
5.9
3.8
mmol/l
2.3
1.8
2.98
697
2536
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1804
10017
2.15
145.75
2.4
1.7
mg/l
1.6
1.4
0.88
1485
7775
(1616796) Gas panel - Central venous blood
456
1246
3.88
144.91
5.4
3.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
891
3640
2.70
144.25
6.1
3.8
kpa
5.2
5.2
0.10
846
3333
(3011412) CD3 cells [#/volume] in Blood
249
412
6.26
144.06
2.3
2.0
e9/l
1.0
1.1
1.72
176
238
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
344
764
4.72
143.69
1.3
1.4
u/ml
33.2
14.2
—
6
14
(3009343) pH of Capillary blood
882
3592
2.71
143.64
6.1
3.8
ph
7.4
7.4
4.47
154
441
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2355
14501
2.04
143.62
5.4
3.1
u/l
34.2
37.0
0.80
2256
13646
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
317
663
5.00
142.27
1.4
1.4
u/ml
132.2
122.7
0.18
66
138
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
809
3182
2.79
140.80
12.1
7.0
mmol/l
25.1
24.8
0.94
799
3152
(3042733) HLA Ab [Presence] in Serum
130
96
13.82
139.99
4.2
5.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1140
5318
2.42
139.31
11.4
7.4
g/l
123.8
120.1
6.64
1103
5123
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
445
1229
3.83
139.16
1.6
1.6
iu/ml
58.1
5.7
0.91
107
285
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4714
37528
2.25
136.32
14.6
7.6
u/l
78.6
80.9
2.71
4613
35088
(3036481) Cortisol [Moles/volume] in Serum or Plasma
935
4022
2.57
135.81
2.2
2.2
nmol/l
343.0
376.2
3.94
879
3673
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
154
161
9.79
132.17
3.6
1.7
ug/l
43.5
59.7
1.43
154
154
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
136
119
11.67
131.99
2.9
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
2018
12036
2.03
131.96
11.0
6.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
671
2476
2.93
131.12
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
903
3894
2.56
130.10
1.6
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1560
8497
2.13
130.10
6.7
3.1
mmol/l
0.8
0.8
1.04
1458
7858
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
204
308
6.82
128.90
2.2
2.0
%
16.2
13.9
0.88
81
128
(1175426) CD3 cells/100 lymphocytes in Blood
207
318
6.71
128.67
2.2
2.0
%
71.5
71.1
0.10
200
295
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
213
341
6.44
127.23
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2250
14079
1.96
127.14
4.7
3.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
197
302
6.71
122.68
2.3
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2468
16074
1.92
122.54
5.0
3.5
e6/l
95.0
108.8
0.11
2021
12595
(3024561) Albumin [Mass/volume] in Serum or Plasma
3179
22573
1.88
119.75
6.4
4.8
g/l
33.3
34.7
33.16
2969
20801
(40767503) Oxygen content in Capillary blood by calculation
412
1196
3.63
119.40
3.5
2.5
%
15.8
16.0
0.24
223
634
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
934
4248
2.42
119.25
1.5
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
421
1241
3.58
119.21
7.2
4.4
kpa
8.2
8.4
1.39
412
1210
(3024471) HLA-A [Type]
121
105
11.74
118.02
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2288
14677
1.91
117.74
4.8
3.3
e6/l
0.4
0.5
0.82
1830
11268
(3024932) HLA-DR beta [Type]
119
101
12.00
117.73
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3156
22458
1.87
117.03
12.7
11.0
inr
1.3
1.3
3.70
1064
6100
(3012501) Base excess in Blood by calculation
415
1235
3.54
115.76
7.2
4.4
mmol/l
2.8
2.7
0.28
319
836
(3013290) Carbon dioxide [Partial pressure] in Blood
415
1236
3.54
115.61
7.2
4.4
kpa
5.0
5.0
0.33
406
1206
(3018095) Leukocytes [#/volume] in Urine
2679
18167
1.87
115.19
5.9
3.9
e6/l
101.7
110.8
0.15
2087
13384
(3015235) Bicarbonate [Moles/volume] in Capillary blood
466
1512
3.26
113.26
4.9
3.0
mmol/l
25.3
24.9
1.26
428
1304
(3010421) pH of Blood
449
1436
3.30
111.70
7.0
4.3
ph
7.4
7.4
1.04
406
1208
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
420
1293
3.42
111.05
3.3
2.3
g/l
3.8
3.6
2.20
408
1225
(3026782) Osmolality of Urine
1776
10640
1.96
110.81
4.0
2.9
mosm/kgh2o
533.0
554.8
4.88
1594
9041
(3008152) Bicarbonate [Moles/volume] in Arterial blood
816
3609
2.46
110.23
8.7
6.6
mmol/l
25.1
24.5
4.46
778
3365
(3021901) Oxygen saturation in Capillary blood
380
1104
3.61
109.84
4.5
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1869
11426
1.93
109.55
3.9
2.7
e6/l
4.6
4.6
0.06
1700
10016
(21494815) CD4 cells/100 lymphocytes in Specimen
198
344
5.92
108.85
2.3
2.0
%
32.5
41.3
1.12
14
43
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1048
5210
2.23
107.83
4.2
3.0
ng/l
239.4
243.0
0.09
986
4780
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
146
186
8.02
107.23
1.5
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
426
1355
3.31
106.82
5.7
3.2
kpa
7.7
7.9
2.26
407
1250
(3013826) Glucose [Moles/volume] in Serum or Plasma
3875
29909
1.85
105.62
8.7
4.9
mmol/l
6.8
6.9
0.64
3731
28147
(3020779) Urea [Moles/volume] in Serum or Plasma
1032
5154
2.21
104.72
11.5
6.8
mmol/l
10.7
11.0
0.74
984
4868
(3010375) cycloSPORINE [Mass/volume] in Blood
140
176
8.12
103.96
44.3
23.2
ug/l
156.4
109.3
7.20
115
143
(3023420) DNA double strand Ab [Units/volume] in Serum
201
371
5.57
103.63
1.9
1.2
iu/ml
22.3
24.9
—
10
16
(40757373) Influenza virus identified in Isolate
112
109
10.45
101.11
2.9
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1194
6511
2.04
95.43
4.5
4.0
u/l
269.4
246.1
4.84
1131
6119
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1328
7524
1.99
95.29
2.9
2.6
%
20.7
21.9
2.70
1127
6335
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
238
550
4.47
94.27
1.3
1.2
u/ml
4.4
3.6
0.12
96
165
(3022948) Iron [Moles/volume] in Serum or Plasma
1462
8590
1.93
94.12
2.9
2.5
umol/l
11.5
12.3
4.92
1381
7887
(3009871) Measles virus Ab [Titer] in Serum
96
83
11.74
93.80
1.3
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
391
1278
3.20
93.53
3.4
2.2
%
89.6
88.4
0.50
375
1213
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
439
1542
2.99
92.75
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1378
7990
1.94
91.99
2.8
2.5
g/l
2.2
2.3
0.55
1285
7346
(4306422)
223
503
4.57
91.05
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
917
4606
2.17
90.67
12.2
7.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2697
19247
1.74
90.26
2.8
2.2
nmol/l
77.8
79.0
1.32
2480
16832
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
219
493
4.57
89.63
1.2
1.1
%
118.7
114.4
0.95
211
435
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
187
373
5.14
88.41
1.4
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
118
147
8.17
88.26
2.2
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1229
6963
1.97
87.25
11.8
6.7
mmol/l
103.8
104.4
4.03
1194
6801
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
226
535
4.35
86.76
1.3
1.2
u/ml
3.4
4.9
1.06
135
231
(3013293) Extractable nuclear Ab [Presence] in Serum
73
45
16.41
86.52
1.5
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
251
645
4.02
86.36
1.2
1.2
u/ml
344.1
288.6
1.14
164
380
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
153
260
6.01
86.00
1.5
1.3
u/ml
1.5
1.4
0.03
95
131
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
174
334
5.34
85.89
2.2
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
117
150
7.94
85.44
1.2
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
114
142
8.17
85.28
41.3
32.0
ug/l
8.1
7.3
2.18
103
127
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
170
323
5.39
84.87
1.1
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
938
4867
2.10
84.82
11.0
6.5
mmol/l
1.5
1.4
1.25
891
4662
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
806
3952
2.20
84.25
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4106
33273
1.76
83.87
6.8
4.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
821
4067
2.18
83.60
2.1
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
597
2591
2.45
82.89
6.4
4.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
170
331
5.26
82.59
1.3
1.2
titre
112.7
130.0
0.20
11
12
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
170
331
5.26
82.59
1.3
1.2
titre
128.0
131.8
0.03
35
55
(3020630) Protein [Mass/volume] in Serum or Plasma
933
4881
2.08
82.35
2.2
2.5
g/l
66.2
66.0
0.23
864
4364
(3028271) Lactate [Moles/volume] in Capillary blood
295
875
3.50
82.33
2.4
1.9
mmol/l
1.7
1.7
0.59
289
852
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
259
705
3.80
82.15
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
354
1181
3.12
81.63
3.6
2.4
%
210.2
203.6
0.64
337
1128
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
128
194
6.72
80.50
1.7
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
128
194
6.72
80.50
1.7
1.9
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
155
285
5.56
80.20
2.2
2.0
e6/l
471.2
524.9
0.48
128
235
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
128
195
6.69
80.11
1.7
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
659
3035
2.32
79.89
14.8
9.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1218
7075
1.91
79.40
7.9
5.7
mmol/l
1.1
1.0
0.72
1133
6515
(21494814) CD8 cells/100 lymphocytes in Specimen
119
170
7.12
79.05
2.1
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
145
256
5.78
78.34
1.7
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
350
1194
3.05
77.61
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
350
1194
3.05
77.61
1.5
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
210
515
4.19
76.93
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
165
335
5.04
76.42
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
297
929
3.31
76.16
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
177
383
4.73
76.02
1.2
1.2
%
96.5
94.2
0.47
172
358
(3036489) Thrombin time
426
1643
2.72
75.29
3.3
2.0
s
21.7
21.8
0.05
389
1481
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2276
16059
1.68
75.24
3.5
2.2
u/l
154.6
227.9
4.60
2149
14945
(3033658) Prothrombin time (PT) actual/Normal
1863
12498
1.72
74.16
6.4
4.0
%
84.4
84.8
0.31
1828
12203
(3026493) Urate [Moles/volume] in Serum or Plasma
1959
13351
1.70
73.39
4.9
2.8
umol/l
2219.4
5525.5
4.76
1724
11331
(3002032) Base excess in Venous blood by calculation
959
5289
1.97
72.28
4.9
3.7
mmol/l
2.3
1.9
2.09
797
4245
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1626
10582
1.74
71.78
5.4
4.1
ng/l
425.2
480.1
0.21
1444
8996
(4268621)
165
354
4.77
71.59
2.3
2.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
143
271
5.38
71.59
2.3
2.1
e9/l
0.2
0.2
0.12
126
235
(3021447) Carbon dioxide [Partial pressure] in Venous blood
956
5303
1.96
70.72
4.9
3.7
kpa
5.9
5.8
1.19
917
5135
(3008536) Aspergillus sp Ab [Presence] in Serum
84
90
9.45
70.71
1.6
1.7
—
—
—
0
0
(4015189)
102
139
7.45
70.67
2.1
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3017
23139
1.62
69.79
4.9
3.9
estimate
0.0
0.0
0.50
831
4277
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
171
386
4.53
69.71
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
890
4839
1.99
69.70
2.3
2.2
g/l
0.2
0.2
1.66
831
4470
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
704
3516
2.14
69.46
2.0
1.7
—
—
—
0
0
(3012544) pH of Venous blood
976
5492
1.93
69.06
4.8
3.7
ph
7.4
7.4
—
8
32
(3017569) Oxygen content in Arterial blood
144
284
5.17
68.95
2.2
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1152
6847
1.85
68.76
3.5
2.4
%
1.9
1.8
5.60
1020
6006
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
659
3249
2.16
67.10
1.7
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3002
23134
1.60
67.01
6.7
5.3
estimate
0.0
0.0
0.50
839
4311
(3015377) Calcium [Moles/volume] in Serum or Plasma
2381
17378
1.62
66.47
4.3
3.4
mmol/l
2.3
2.3
3.06
2137
14850
(3009261) Glucose [Presence] in Urine by Test strip
3029
23458
1.60
65.70
5.0
4.0
estimate
0.0
0.0
1.60
816
4188
(3031040) Bacteria [#/volume] in Urine by Automated count
3943
32584
1.63
64.62
6.4
4.9
e6/l
744.1
1855.2
1.55
64
564
(3014007) Fractional oxyhemoglobin in Arterial blood
693
3538
2.09
64.28
14.2
8.5
%
92.3
93.9
9.82
687
3522
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
810
4389
1.98
63.65
5.0
4.0
mmol/l
1.2
1.2
2.75
739
3817
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
127
251
5.15
60.67
2.1
1.5
u/l
6.0
6.7
0.41
112
213
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
551
2638
2.20
60.15
4.9
3.9
mmol/l
24.4
24.1
1.49
496
2360
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
119
225
5.38
59.74
1.1
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
172
439
4.01
59.68
1.1
1.1
iu/ml
1.8
2.3
—
9
12
(3034426) Prothrombin time (PT)
85
117
7.36
58.38
1.1
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
674
3526
2.03
58.20
14.4
8.5
%
0.6
0.7
0.92
666
3497
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1311
8443
1.71
58.20
2.8
2.0
s
30.0
30.2
0.50
1281
8173
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1309
8442
1.71
57.75
4.2
3.2
e6/l
1.6
1.9
0.89
742
4798
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
672
3540
2.01
56.85
14.4
8.4
%
1.4
1.3
1.93
664
3516
(40761536) Microorganisms panel - Urine sediment
738
4044
1.94
55.66
5.3
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2663
20522
1.54
55.44
5.3
4.1
ng/l
104.5
80.1
0.15
2137
15666
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
64
66
9.79
55.39
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
459
2107
2.28
55.37
3.9
2.8
u/ml
0.3
0.3
0.75
281
1191
(3023520) Reticulocytes [#/volume] in Blood
888
5198
1.83
54.49
3.4
2.5
e9/l
73.3
67.8
3.43
623
3972
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
120
248
4.92
54.46
2.5
2.6
%
39.1
36.1
0.65
54
90
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2499
19085
1.54
53.64
3.4
2.9
ug/l
201.8
156.1
7.34
2294
17286
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
73
93
7.93
53.59
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
74
98
7.63
52.57
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
136
323
4.29
51.98
2.6
2.3
ph
7.4
7.4
0.39
83
107
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
88
144
6.19
51.41
2.2
2.0
%
30.4
30.0
0.07
83
131
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1901
13764
1.56
51.40
2.6
2.3
mg/l
3.3
3.1
2.80
1673
11619
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
188
569
3.38
50.74
1.1
1.1
g/l
1.6
1.6
0.03
166
508
(3006245) CD3-CD19+ cells/100 cells in Blood
87
143
6.16
50.60
2.2
2.0
%
9.6
12.4
0.79
80
126
(3002385) Erythrocyte distribution width [Ratio]
4246
36580
1.57
50.41
38.1
20.4
%
14.3
13.9
62.24
4209
35681
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
127
297
4.35
49.53
2.4
2.0
e6/l
634.8
600.8
0.19
57
128
(3020891) Body temperature
467
2259
2.16
49.38
5.8
4.6
—
—
—
0
0
(4035726)
763
4390
1.85
49.14
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
915
5593
1.75
48.02
5.0
3.7
—
—
—
0
0
(3015736) pH of Urine
2370
18192
1.50
47.98
4.2
3.7
—
5.8
—
0
18
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1333
9032
1.61
47.16
3.9
3.0
e6/l
1.0
1.2
1.23
769
5346
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
52
51
10.28
46.62
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
475
2370
2.09
46.26
6.0
4.9
%
1.8
1.6
3.88
448
2219
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
246
924
2.73
45.52
1.4
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
448
2221
2.10
44.33
7.3
4.3
mmol/l
25.1
24.8
1.33
426
2022
(3047181) Lactate [Moles/volume] in Blood
373
1721
2.25
44.26
8.4
5.8
mmol/l
1.4
1.3
0.64
343
1521
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
889
5507
1.72
44.19
3.1
2.7
umol/l
10.5
9.3
0.64
776
4802
(3024354) Oxygen [Partial pressure] in Venous blood
739
4351
1.80
43.83
3.8
3.1
kpa
4.5
4.5
0.07
705
4197
(3004809) Band form neutrophils/100 leukocytes in Blood
245
945
2.66
43.04
4.1
3.6
%
1.5
1.5
0.01
214
701
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2835
22926
1.45
42.16
3.0
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
268
1092
2.52
42.08
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
95
201
4.79
41.98
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
236
907
2.67
41.75
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
299
1299
2.37
40.81
1.5
1.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
37
26
14.31
40.76
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
523
2822
1.94
40.73
1.9
1.7
g/l
1.6
1.6
0.68
439
2404
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
398
1948
2.12
40.66
3.5
2.2
ug/l
387.3
638.7
1.18
377
1847
(3034860) Kappa light chains.free [Mass/volume] in Serum
397
1948
2.11
40.29
2.5
3.2
mg/l
62.0
92.4
0.52
287
1612
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
396
1944
2.11
40.13
2.5
3.2
mg/l
43.4
54.6
0.75
285
1609
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
89
187
4.82
39.66
1.2
1.2
ratio
1.1
1.1
0.09
34
61
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
386
1900
2.10
38.83
2.5
3.2
ratio
4.1
3.5
0.12
25
148
(3041096) Erythrocytes [Presence] in Urine by Automated
1635
12021
1.50
38.82
5.0
3.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
253
1043
2.49
38.74
1.9
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
230
917
2.57
37.78
1.7
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
75
142
5.34
37.66
1.1
1.1
u/ml
27.9
6.6
—
10
14
(3052851) Hemolysis interference index of Serum or Plasma
340
1612
2.18
37.65
4.4
3.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
402
2050
2.03
36.72
4.7
3.8
mmol/l
1.4
1.4
0.27
396
2016
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
353
1716
2.12
36.66
2.4
2.2
g/l
0.1
0.1
0.10
327
1551
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
150
483
3.16
36.65
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
443
2342
1.96
36.53
6.4
5.0
%
0.9
0.9
0.26
415
2197
(3029937) Albumin [Presence] in Urine by Test strip
1708
12802
1.47
36.35
5.4
4.4
estimate
0.0
0.0
0.88
779
4075
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
332
1591
2.15
35.76
2.4
2.2
g/l
0.0
0.0
1.04
306
1431
(3039000) Anion gap in Blood
279
1246
2.30
35.71
8.4
6.6
mmol/l
11.7
11.2
1.76
256
1112
(3018572) Chloride [Moles/volume] in Blood
279
1246
2.30
35.71
8.4
6.7
mmol/l
103.8
105.1
4.84
256
1112
(3007853) Bacteria identified in Skin by Aerobe culture
899
5882
1.62
35.60
2.2
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
327
1561
2.16
35.57
2.4
2.2
g/l
0.0
0.0
0.00
306
1425
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
413
2152
1.99
35.49
2.4
2.3
g/l
3.3
3.1
4.10
334
1666
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2324
1.95
35.07
2.3
2.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
414
2168
1.98
35.06
2.4
2.3
g/l
10.6
10.2
0.75
353
1806
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2326
1.94
34.98
2.3
2.3
g/l
7.9
7.4
4.37
338
1690
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
435
2320
1.94
34.93
2.3
2.3
g/l
3.9
3.8
0.34
330
1628
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2020
15725
1.43
34.79
3.0
2.6
u/l
61.5
58.8
0.41
1885
14450
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5003
45941
1.57
33.74
34.8
16.9
mg/l
25.3
26.9
3.44
4687
37477
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
380
1960
2.00
33.58
2.4
2.3
g/l
0.7
1.0
0.98
337
1655
(3026008) Bacteria identified in Urine by Culture
2035
15962
1.42
33.20
3.8
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
236
1012
2.39
33.16
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
352
1793
2.02
32.20
2.4
2.1
g/l
35.9
37.4
4.53
319
1503
(3029075) Extractable nuclear Ab panel - Serum
57
97
5.92
32.07
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
3840
33639
1.40
32.01
5.8
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
141
476
3.01
31.81
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
299
1460
2.10
30.65
2.4
3.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
55
98
5.66
29.52
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
962
6652
1.53
29.50
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
245
1125
2.23
29.35
1.2
1.2
titre
107.1
93.9
0.22
28
71
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1343
9987
1.45
28.56
3.0
3.1
mmol/l
2.5
2.5
8.49
1192
8699
(3034770) Mitochondria Ab [Titer] in Serum
244
1133
2.20
28.44
1.2
1.2
titre
977.5
966.3
0.01
12
35
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
323
1697
1.96
27.02
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
164
657
2.54
26.73
1.1
1.3
miu/ml
195.3
206.7
0.11
23
239
(3011397) Hemoglobin [Presence] in Urine by Test strip
1469
11217
1.41
26.69
4.3
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
282
1434
2.01
25.90
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3222
27921
1.34
25.74
4.4
3.1
u/l
66.1
55.2
5.01
2995
25352
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2167
17718
1.35
25.60
5.3
4.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
550
3444
1.66
25.48
4.7
3.3
g/l
125.8
127.6
1.12
531
3355
(3000060) B lymphocytes [#/volume] in Blood
50
94
5.36
25.37
2.3
1.9
e6/l
958.8
1629.0
0.21
25
40
(3043409) Potassium [Moles/volume] in Arterial blood
321
1727
1.91
25.02
5.4
4.1
mmol/l
4.0
3.9
2.49
293
1606
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1147
8481
1.44
24.68
1.3
1.2
u/ml
1.1
1.7
3.18
291
2095
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
115
404
2.88
24.24
1.8
1.8
mg/l
4.5
4.6
0.06
107
385
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
50
98
5.14
24.23
1.1
1.1
%
89.0
82.0
0.70
32
53
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
63
150
4.23
24.14
1.3
2.1
%
197.5
167.9
1.17
57
141
(3036782) Glucose [Moles/volume] in Pleural fluid
150
613
2.48
23.49
1.5
1.4
mmol/l
6.6
6.4
0.30
136
565
(3051651) Icteric interference index of Serum or Plasma
97
315
3.11
23.48
5.8
3.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
52
109
4.80
23.34
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
58
133
4.39
23.33
2.4
2.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
249
1267
2.01
22.84
3.5
3.0
mg/l
1.8
1.7
0.64
230
1125
(3008757) Leukocyte morphology finding [Identifier] in Blood
148
611
2.46
22.68
4.9
4.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
398
2358
1.74
22.60
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
156
661
2.40
22.59
1.2
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
29
9
32.37
22.37
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
148
616
2.44
22.29
1.7
1.5
%
59.1
62.4
0.45
89
406
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
49
102
4.84
22.18
1.1
1.3
%
89.7
80.4
0.82
34
58
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
667
4517
1.54
22.08
2.7
2.4
u/l
36.2
48.1
0.57
605
3840
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
123
471
2.65
22.04
1.9
1.4
%
39.1
26.1
3.17
72
301
(3027273) Bicarbonate [Moles/volume] in Venous blood
455
2825
1.66
21.70
4.6
3.4
mmol/l
25.6
25.1
2.07
430
2738
(3003327) Ova and parasites identified in Stool by Light microscopy
235
1201
2.00
21.31
1.9
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
262
1406
1.90
20.59
1.6
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
118
459
2.60
20.52
1.7
1.5
u/l
14.2
13.2
0.73
113
439
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
48
105
4.60
20.50
1.6
1.4
ug/l
8.2
9.4
0.96
48
105
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
605
4080
1.54
20.35
1.7
1.7
%
1.7
1.6
2.04
509
3442
(3045142) Bone marrow Pathology biopsy report
143
613
2.37
20.21
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
240
1262
1.94
20.05
1.8
1.6
e6/l
13794.1
14620.8
0.09
182
913
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
42
85
4.97
19.67
1.5
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
393
2409
1.68
19.67
2.7
1.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
74
228
3.27
19.60
1.7
1.4
%
3.9
4.0
0.05
20
58
(3045716) Anion gap in Serum or Plasma
80
259
3.12
19.53
2.1
2.2
mmol/l
8.5
9.4
1.34
63
206
(3023183) Ammonium ion [Moles/volume] in Plasma
218
1124
1.98
19.30
2.7
2.5
umol/l
33.3
34.7
0.32
192
937
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
38
72
5.31
19.16
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1432
11387
1.34
19.14
1.9
1.8
nmol/l
1187.6
1163.4
0.40
1086
8497
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
120
489
2.48
18.98
1.3
1.3
u/l
14.8
13.4
0.25
108
448
(3004451) EKG impression Narrative
86
296
2.93
18.90
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
198
1003
2.01
18.44
1.8
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
152
699
2.21
18.25
1.6
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
142
636
2.26
18.17
1.4
1.3
u/l
482.0
378.6
0.61
131
600
(3044941) Cell count panel - Synovial fluid
168
814
2.09
17.67
1.8
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
469
3082
1.57
17.65
3.3
3.3
e9/l
4.6
4.2
1.96
374
2208
(3003434) Protein [Mass/volume] in Pleural fluid
183
918
2.03
17.53
1.5
1.5
g/l
32.6
31.3
0.63
158
820
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
161
770
2.12
17.52
1.2
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
406
2588
1.61
17.39
3.9
2.7
%
0.7
0.7
0.78
398
2478
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
36
71
5.10
17.38
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2226
18974
1.28
17.38
2.4
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1594
13023
1.31
17.27
1.8
1.6
nmol/l
18.9
20.1
2.41
1423
11023
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
78
268
2.94
17.23
4.0
3.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
156
743
2.13
17.17
8.1
6.3
mg/l
12.0
12.0
0.10
145
682
(3016650) Hepatitis A virus Ab [Presence] in Serum
137
621
2.23
17.06
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
40
88
4.57
17.01
1.6
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
86
314
2.76
16.99
1.7
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
171
854
2.03
16.60
2.9
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
121
533
2.30
16.15
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
130
592
2.22
16.03
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
638
4585
1.44
15.49
2.3
2.1
ug/g
194.6
164.4
0.97
522
3557
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
22
30
7.36
15.24
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
131
615
2.16
15.01
1.6
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
112
493
2.30
15.00
1.1
1.2
u/l
56.8
63.5
0.57
90
326
(40768806) Pleura Pathology biopsy report
144
703
2.07
14.91
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
275
1651
1.70
14.90
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
85
331
2.59
14.86
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
206
1141
1.83
14.74
3.9
2.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
123
568
2.19
14.69
5.4
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
106
462
2.32
14.54
1.3
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
60
196
3.08
14.53
4.2
3.8
%
60.6
54.5
1.30
60
189
(3000570) Elastase.pancreatic [Mass/mass] in Stool
250
1477
1.72
14.37
1.4
1.5
ug/g
290.2
264.9
0.43
156
890
(40768446) Kidney Pathology biopsy report
52
158
3.31
14.18
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
570
4101
1.43
13.70
4.3
3.8
ng/l
104.9
96.9
0.81
495
3456
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
557
3992
1.44
13.68
3.8
2.8
ml/min/173m2
56.7
60.9
1.93
268
1695
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
35
83
4.24
13.59
1.7
1.8
mg/l
6.2
9.0
2.03
29
69
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
342
2227
1.57
13.39
2.3
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
32
72
4.46
13.28
1.3
1.2
ng/l
120.2
1242.3
0.50
21
48
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3691
33920
1.23
13.14
4.1
3.8
pmol/l
15.0
15.0
0.26
3333
30180
(21494567) Legionella sp IgM Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
147
769
1.93
12.60
1.6
1.9
ug/l
23.1
23.8
0.06
142
751
(3050794) Legionella sp Ab [Presence] in Serum
23
41
5.63
12.40
1.1
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
29
66
4.41
11.89
1.0
1.2
%
93.4
75.8
—
10
24
(3044927) Protein electrophoresis panel - Urine
124
625
2.01
11.85
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
226
1375
1.67
11.71
3.0
3.1
nmol/l
0.9
0.8
0.38
176
1033
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2552
22747
1.21
11.70
5.2
4.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
15
9.35
11.65
1.4
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
44
5.24
11.52
1.0
1.0
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
0.8
0.9
—
7
11
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
3.4
2.7
—
7
11
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.5
3.5
—
9
12
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.2
3.3
—
6
10
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
6.2
1.2
—
5
12
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.8
0.6
—
8
11
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
5.2
2.2
—
6
10
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.3
1.3
—
6
12
(3040151) Glucose [Moles/volume] in Capillary blood
130
674
1.95
11.48
15.0
18.6
mmol/l
7.5
7.5
0.06
114
555
(3010726) Horse dander IgE Ab [Units/volume] in Serum
77
326
2.38
11.37
1.1
1.1
u/ml
2.6
1.5
0.38
29
85
(3023430) Cat dander IgE Ab [Units/volume] in Serum
65
255
2.57
11.29
1.0
1.1
u/ml
1.6
3.3
0.84
34
102
(3023199) Leukocytes [#/volume] in Pleural fluid
148
806
1.86
11.27
1.6
1.5
e6/l
4879.0
1826.6
0.62
100
585
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
75
317
2.38
11.13
2.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
78
336
2.34
11.09
1.4
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
68
276
2.48
11.02
1.0
1.1
u/ml
3.5
2.6
0.24
34
113
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
19
7.91
11.00
1.6
1.3
mg/l
0.2
2.2
—
5
13
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
28
66
4.26
11.00
1.1
1.2
%
77.0
82.1
—
9
23
(3028308) Erythrocytes [#/volume] in Pleural fluid
136
727
1.89
10.98
1.6
1.5
e6/l
128625.3
60188.1
0.95
78
430
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
94
443
2.14
10.79
1.1
1.1
u/ml
1.5
2.4
0.41
48
180
(3035880) pH of Pleural fluid
83
372
2.25
10.78
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1371
11542
1.24
10.74
1.8
1.7
pmol/l
39405345.0
26490209.3
0.27
1109
9347
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
45
150
3.02
10.62
1.1
1.1
u/ml
14.3
2.3
1.08
11
20
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
193
1158
1.69
10.57
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
72
307
2.36
10.50
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
682
5273
1.33
10.46
2.6
2.4
ug/l
10.9
6.8
4.17
597
4536
(3009508) Creatinine [Moles/volume] in Urine
1880
16394
1.21
10.44
3.6
3.2
mmol/l
7.1
7.4
1.79
1559
13483
(3017354) Segmented neutrophils/100 leukocytes in Blood
114
586
1.96
10.36
4.6
3.5
%
54.5
59.4
1.39
83
352
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
68
285
2.40
10.31
1.1
1.2
u/l
95.8
92.6
0.10
62
243
(3022493) Free Hemoglobin [Mass/volume] in Plasma
57
220
2.61
10.27
5.9
4.5
mg/l
61.9
69.0
0.45
45
150
(3003888) Timothy IgE Ab [Units/volume] in Serum
84
387
2.19
10.22
1.1
1.1
u/ml
3.9
3.8
0.03
48
185
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
66
274
2.42
10.22
1.1
1.2
u/l
44.2
24.9
1.25
60
229
(44806071)
21
42
5.01
10.03
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
123
659
1.88
9.90
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1836
16045
1.21
9.84
3.6
3.2
mg/l
682.9
316.7
2.02
1234
10292
(40768443) Skin Pathology biopsy report
325
2243
1.48
9.74
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
45
159
2.84
9.61
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2459
22108
1.19
9.61
2.2
2.1
pmol/l
91.3
93.1
1.06
1336
11609
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
11
10.02
9.54
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
136
762
1.80
9.52
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
54
4.27
9.11
1.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
19
38
5.01
9.08
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
641
5013
1.31
9.04
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
55
223
2.48
9.00
1.0
1.0
u/ml
0.2
0.3
0.18
23
72
(40761511) CBC panel - Blood by Automated count
4887
46874
1.24
8.97
27.3
16.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1816
15975
1.20
8.87
3.2
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
48
184
2.62
8.82
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
73
339
2.17
8.77
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4209
39821
1.20
8.68
34.0
18.2
%
38.8
38.8
0.16
2670
25221
(3022145) Colonoscopy Study observation
663
5263
1.29
8.35
1.3
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
39
139
2.82
8.25
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
92
477
1.94
8.24
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1909
16964
1.18
8.16
4.5
4.0
mg/mmol
12.8
9.7
1.53
1240
10779
(3008401) Mugwort IgE Ab [Units/volume] in Serum
77
377
2.06
8.10
1.1
1.1
u/ml
0.5
1.4
1.35
37
162
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
516
6618
0.76
8.08
9.8
8.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
11
14
7.87
7.98
1.8
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
65
302
2.17
7.84
1.4
1.6
u/l
8.9
6.4
0.60
37
140
(3006576) Bicarbonate [Moles/volume] in Blood
46
184
2.51
7.80
5.7
6.8
mmol/l
24.5
24.6
0.03
39
165
(36660697) Celiac disease serology panel - Serum
411
3078
1.36
7.79
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
55
239
2.31
7.79
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
55
240
2.30
7.72
1.1
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5004
48291
1.23
7.65
35.7
20.1
mmol/l
139.0
139.6
47.10
4943
46988
(3036603) Volume of Urine
68
325
2.10
7.65
1.4
1.7
ml
1834.5
1813.2
0.04
19
87
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
12
8.35
7.58
1.1
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
49
207
2.38
7.41
1.3
1.3
mmol/l
3.7
3.5
0.15
43
186
(3022217) INR in Platelet poor plasma by Coagulation assay
970
8167
1.22
7.30
29.9
29.5
inr
1.5
1.5
0.04
102
1144
(3006922) Hepatitis E virus Ab [Presence] in Serum
56
253
2.23
7.27
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
720
5881
1.26
7.16
3.2
4.0
ug/l
14.2
23.6
1.16
594
4872
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
20
51
3.93
7.15
1.6
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5006
48382
1.22
7.13
36.0
20.3
mmol/l
4.0
4.0
3.30
4938
47011
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
76
389
1.97
7.13
1.6
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
10
13
7.70
7.12
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
70
3.44
7.10
1.4
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
100
562
1.79
7.04
2.6
3.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
76
394
1.94
6.88
1.6
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
153
972
1.59
6.83
1.4
1.3
mmol/l
66.0
62.5
0.51
138
780
(3014765) Yersinia sp identified in Stool by Organism specific culture
192
1289
1.51
6.70
1.3
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
49
217
2.27
6.69
1.4
1.4
%
1.4
2.5
0.78
36
183
(42529406) Shigella sp [Presence] in Stool by Culture
193
1298
1.50
6.68
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
59
287
2.07
6.40
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
59
287
2.07
6.40
1.7
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
107
2.81
6.40
1.3
1.5
%
4.0
6.0
0.57
16
51
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
34
130
2.62
6.37
6.4
7.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4345
41594
1.17
6.30
5.1
4.7
mu/l
2.1
2.1
0.09
3964
37219
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
379
2901
1.33
6.25
2.6
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
188
1277
1.49
6.23
1.3
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
33
126
2.63
6.21
5.2
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1385
12217
1.17
6.15
3.1
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
311
2317
1.36
6.15
2.6
3.3
pmol/l
4.2
4.4
1.72
267
2014
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
68
355
1.93
6.08
1.1
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
20
58
3.46
6.00
1.3
1.0
iu/ml
6.3
6.9
0.10
12
23
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
45
203
2.23
5.93
1.1
1.1
iu/ml
7.6
13.4
—
6
49
(3041918) Cholesterol [Moles/volume] in Pleural fluid
32
124
2.59
5.86
1.2
1.2
mmol/l
2.0
1.6
1.10
15
81
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
515
6350
0.79
5.84
4.7
4.8
%
32.4
33.1
0.69
377
4127
(44813793)
50
237
2.12
5.84
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
27
96
2.82
5.82
1.3
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
174
2.31
5.74
3.4
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
174
2.31
5.74
3.4
2.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
54
268
2.02
5.60
1.4
1.4
%
60.3
68.9
0.78
36
218
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
21
66
3.19
5.58
1.5
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4989
48434
1.19
5.53
20.7
11.1
u/l
24.8
25.6
2.58
4922
46304
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
57
290
1.97
5.53
2.4
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
163
1104
1.49
5.52
1.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
84
486
1.74
5.45
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
41
186
2.21
5.36
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
58
301
1.94
5.33
2.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
85
498
1.72
5.29
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
140
929
1.52
5.25
1.2
1.3
u/l
45.5
40.3
0.12
123
803
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
148
994
1.50
5.24
1.1
1.1
u/ml
19.8
8.5
0.66
11
78
(3037121) Protein [Mass/volume] in Urine
249
1847
1.36
5.12
2.8
3.0
g/l
0.4
0.3
0.73
126
779
(21494755) Public health laboratory ask at order entry panel
137
2017
0.67
5.06
1.3
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
27
4.45
5.03
1.4
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
30
122
2.47
5.03
1.7
1.5
ug/l
0.3
0.4
0.57
23
67
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4470
43109
1.15
5.01
6.9
6.5
mmol/mol
41.5
40.8
3.91
4136
39177
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
36
3.90
4.98
1.1
1.1
g/l
0.1
0.1
—
7
28
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
49
246
2.00
4.97
1.2
1.1
u/l
33.4
35.5
0.07
40
177
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
49
246
2.00
4.97
1.2
1.1
u/l
94.4
92.6
0.04
41
182
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
104
655
1.60
4.93
1.6
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
59
317
1.87
4.92
1.0
1.0
mg/l
293.8
285.3
0.41
54
279
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4458
43008
1.15
4.89
29.3
16.1
ml/min/173m2
73.4
74.2
1.50
4026
35673
(3020491) Glucose [Moles/volume] in Blood
65
363
1.80
4.80
2.1
2.2
mmol/l
7.5
6.8
1.05
53
238
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
165
2322
0.70
4.79
1.9
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
104
661
1.58
4.76
1.6
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
17
52
3.28
4.74
2.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
103
655
1.58
4.71
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
103
655
1.58
4.71
1.6
1.4
—
—
—
0
0
(3013512) EKG study
1699
15475
1.14
4.66
5.2
4.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
103
657
1.58
4.65
1.6
1.4
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
14
38
3.69
4.64
1.3
1.3
ml/s/173m2
0.8
0.8
—
8
25
(3016750) Collection duration of Urine
58
318
1.83
4.56
2.2
2.0
min
476.0
493.3
0.52
37
221
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
19
64
2.98
4.55
1.3
1.3
nmol/l
12.0
146303.6
0.49
14
54
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
104
670
1.56
4.51
1.6
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
129
2.33
4.49
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
27
111
2.44
4.45
6.2
7.8
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
21
76
2.77
4.44
1.5
1.4
%
71.1
74.5
0.19
15
63
(44786800) Granulocytes/100 leukocytes in Body fluid
24
94
2.56
4.37
1.3
1.3
%
18.8
21.3
0.11
13
67
(3002523) Influenza virus A Ag [Presence] in Specimen
68
397
1.72
4.35
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
46
239
1.93
4.28
1.5
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
18
61
2.96
4.27
1.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
36
171
2.11
4.27
1.4
1.4
%
23.7
21.4
0.16
23
139
(3045424) Erythrocytes [Presence] in Urine
122
826
1.49
4.23
1.8
1.5
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
18
62
2.91
4.16
1.6
1.2
ug/l
102.4
119.6
—
10
36
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
62
2.91
4.16
1.3
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
62
2.91
4.16
2.1
1.4
umol/l
41.7
42.7
0.06
18
62
(3010144) Erythrocytes [#/volume] in Synovial fluid
82
510
1.62
4.15
1.7
1.3
e6/l
105988.9
109439.8
0.02
56
357
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
160
2.13
4.14
5.6
1.8
umol/l
152.9
130.5
0.18
21
98
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
57
2.99
4.11
1.1
1.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
47
250
1.89
4.10
1.7
2.4
ml
1994.8
1890.3
0.37
39
209
(21494890) Protein electrophoresis panel - 24 hour Urine
96
623
1.55
4.07
1.5
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
224
1698
1.33
4.07
1.4
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
67
398
1.69
4.06
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
45
237
1.91
4.05
1.5
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
68
407
1.68
4.01
5.8
2.3
%
10.8
10.9
0.08
68
407
(3016038) Potassium [Moles/volume] in Urine
62
365
1.71
3.89
1.3
1.1
mmol/l
32.5
34.4
0.33
57
306
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
68
419
1.63
3.62
1.9
1.9
u/l
5101.3
2495.0
0.27
20
157
(3005011) Chlamydia sp Ab [Titer] in Serum
15
51
2.95
3.57
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
102
1477
0.69
3.56
1.6
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
58
345
1.69
3.54
3.0
2.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
80
517
1.55
3.51
1.4
1.3
mosm/kgh2o
272.1
277.6
1.25
70
387
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
39
208
1.88
3.43
1.2
1.3
ug/l
118.5
530.0
1.07
15
108
(3020393) Adenovirus Ag [Presence] in Stool
14
47
2.98
3.41
1.2
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
47
2.98
3.41
3.6
2.6
mg/l
0.7
1.1
—
7
35
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
18
5.01
3.36
7.3
8.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
21
89
2.36
3.31
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
219
1.83
3.26
1.4
1.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
54
2.78
3.25
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1339
12259
1.12
3.22
1.8
1.6
mmol/l
1.4
1.3
3.75
1098
10155
(3044009) aPTT.lupus sensitive (LA screen)
10
28
3.58
3.19
1.4
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
10
28
3.58
3.19
1.5
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
50
295
1.70
3.18
1.7
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
190
1.85
2.96
2.9
2.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
17
4.71
2.91
1.6
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
50
303
1.66
2.91
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
79
1150
0.68
2.90
1.7
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
14
52
2.70
2.88
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
93
651
1.44
2.85
1.6
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
22
103
2.14
2.80
1.2
1.2
mg/l
0.8
97.1
0.80
14
77
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
498
4318
1.17
2.73
1.7
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
98
2.15
2.70
1.3
1.2
mmol/l
0.5
1.9
1.28
12
67
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
10
6.01
2.69
1.3
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1273
11736
1.11
2.66
1.5
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
25
127
1.97
2.59
1.0
1.1
miu/ml
1727.0
1647.2
0.10
25
127
(3004775) Volume in Urine collected for unspecified duration
68
458
1.49
2.56
2.3
2.2
ml
589.9
649.6
0.62
45
280
(3016135) IgD [Mass/volume] in Serum
5
7
7.15
2.55
1.4
1.3
mg/l
242.2
121.5
—
5
7
(3017446) Testosterone [Moles/volume] in Serum or Plasma
420
3616
1.17
2.53
2.6
2.1
nmol/l
12.3
12.0
0.30
360
3113
(3034274) Bile acid [Moles/volume] in Serum --fasting
38
224
1.70
2.49
1.1
1.6
umol/l
5.7
11.0
1.10
28
150
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
26
3.47
2.48
1.1
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
21
3.81
2.46
1.6
1.1
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
19
89
2.14
2.44
1.3
1.2
u/l
383.8
415.8
0.03
12
63
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
64
431
1.49
2.43
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
189
1513
1.26
2.41
1.6
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1650
17567
0.92
2.41
4.2
4.7
%
21.8
22.2
0.41
750
9298
(3000330) Specific gravity of Urine by Test strip
234
2838
0.82
2.40
4.9
3.7
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
5
8
6.25
2.37
2.6
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
58
2.42
2.36
4.1
4.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.64
2.36
2.1
5.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
41
252
1.63
2.32
1.6
1.3
nmol/l
1.2
1.2
0.11
31
189
(3030313) Adrenal Ab [Titer] in Serum
7
18
3.89
2.25
1.3
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
18
3.89
2.25
1.3
1.7
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
9
5.56
2.21
2.4
4.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
31
181
1.72
2.14
1.2
1.2
g/l
32.3
40.7
2.07
14
89
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
74
2.17
2.14
1.3
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
88
2.05
2.11
2.4
1.4
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
11
43
2.56
2.09
1.3
1.2
mmol/l
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
103
778
1.33
2.09
1.4
1.4
u/l
10.1
10.5
0.12
82
629
(40758292) HTLV I+II Ab panel - Serum
14
62
2.26
2.07
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1124
10425
1.10
2.06
5.3
4.4
kg/l
1.0
1.0
0.04
204
1619
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
24
132
1.82
2.03
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
50
2.40
2.02
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
58
826
0.70
2.00
1.7
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
260
2201
1.19
1.98
1.2
1.2
iu/ml
118.8
139.2
0.38
77
771
(3024731) MCV [Entitic volume]
5069
49938
1.10
1.97
45.3
24.7
fl
92.5
91.6
27.56
5023
48989
(3035941) MCH [Entitic mass]
5069
49938
1.10
1.97
45.2
24.7
pg
30.5
30.4
0.49
5025
48989
(3007461) Platelets [#/volume] in Blood
5068
49929
1.10
1.96
45.5
24.8
e9/l
245.2
240.5
4.98
4986
48388
(3026361) Erythrocytes [#/volume] in Blood
5069
49941
1.10
1.95
45.5
24.8
e12/l
4.4
4.4
15.05
4970
48215
(3010813) Leukocytes [#/volume] in Blood
5070
49953
1.10
1.95
45.5
24.8
e9/l
7.8
6.9
68.46
4974
48215
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
39
2.57
1.92
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
39
2.57
1.92
1.3
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
15
71
2.12
1.92
1.2
1.2
u/l
19.4
19.4
—
8
49
(3000963) Hemoglobin [Mass/volume] in Blood
5069
49953
1.10
1.90
45.8
25.0
g/l
131.3
133.7
23.52
5024
49013
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
331
1.48
1.90
1.4
1.3
promille
1.1
1.2
0.08
38
251
(3044290) Cell count panel - Cerebral spinal fluid
110
852
1.30
1.89
1.2
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
29
173
1.68
1.89
2.2
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
104
800
1.31
1.89
1.4
1.4
iu/l
33.5
30.4
0.38
80
683
(3019174) dRVVT (LA screen)
8
28
2.86
1.86
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
205
1.61
1.85
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
23
129
1.79
1.85
1.9
2.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
35
2.57
1.80
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
153
1.70
1.79
1.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
44
295
1.50
1.79
1.7
1.8
u/field
1.5
2.8
0.75
34
203
(3038177) Helicobacter pylori Ab [Presence] in Serum
77
572
1.35
1.79
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
322
2801
1.16
1.78
2.4
2.4
au/ml
53.7
26.3
—
6
103
(1761482) Bacteria [#/volume] in Urine by Culture
126
1572
0.80
1.77
5.8
4.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
32
200
1.60
1.76
1.1
1.2
%
60.7
62.5
—
6
27
(3052592) Norovirus Ag [Presence] in Stool
22
124
1.78
1.75
2.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
292
2526
1.16
1.75
1.3
1.3
au/ml
44.8
58.3
—
8
104
(3040893) Potassium [Moles/volume] in Capillary blood
6
18
3.34
1.74
2.8
1.9
mmol/l
4.3
4.4
—
6
18
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
395
0.61
1.69
2.0
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
92
709
1.30
1.68
2.8
2.1
mg/l
24.2
25.7
0.11
31
169
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
203
1.58
1.67
1.3
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
62
452
1.38
1.64
1.5
1.6
u/ml
14.2
25.9
—
10
105
(3035637) Corticotropin [Mass/volume] in Plasma
76
573
1.33
1.63
1.6
1.5
—
—
—
0
0
(4027681)
30
189
1.59
1.62
1.2
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
26
2.69
1.58
1.0
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
22
129
1.71
1.56
1.3
1.3
g/l
0.4
0.3
1.17
14
101
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
92
1.85
1.55
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
43
297
1.45
1.55
2.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
249
1.49
1.52
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
49
679
0.72
1.51
1.6
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
93
1.83
1.51
2.0
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
44
0.00
1.51
0.0
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
108
1.76
1.50
1.4
1.1
pmol/l
302.4
267.3
—
10
76
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
86
1.86
1.50
5.4
7.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
72
1.95
1.48
12.4
13.3
mmol/l
5.7
5.3
0.49
14
72
(3023511) Choriogonadotropin [Units/volume] in Urine
28
178
1.58
1.48
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
45
317
1.42
1.47
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
7
28
2.50
1.45
1.4
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
377
0.64
1.43
1.0
1.0
ng/l
313.9
328.3
0.08
13
244
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
46
2.18
1.39
1.1
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
46
2.18
1.39
1.2
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
89
1.80
1.37
1.2
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
95
759
1.26
1.36
1.3
1.7
mu/l
310.7
302.7
0.10
86
698
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.94
1.36
1.2
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
21
128
1.64
1.33
1.0
1.2
%
22.7
29.0
—
6
18
(3020650) Glucose [Presence] in Urine
18
105
1.72
1.33
1.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
122
1007
1.22
1.31
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
113
1.68
1.31
1.2
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
379
0.66
1.29
1.0
1.0
ng/l
35.4
45.0
0.42
14
242
(3032057) Clostridioides difficile [Presence] in Stool
23
145
1.59
1.28
2.1
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
26
169
1.54
1.28
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
72
562
1.28
1.27
1.6
1.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
377
0.66
1.26
1.0
1.0
ng/l
793.7
686.3
0.85
13
236
(40757494) Bilirubin.total [Moles/volume] in Blood
42
303
1.39
1.24
2.5
2.7
umol/l
23.4
34.2
—
5
27
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
168
0.54
1.18
1.7
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
228
2007
1.14
1.16
3.1
3.3
u/ml
12013.2
1553.1
0.42
186
1714
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.6
9.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
110
1.64
1.15
1.2
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
264
2960
0.89
1.14
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
734
0.77
1.14
2.0
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
56
430
1.31
1.14
1.0
1.1
u/ml
17.3
2.6
0.78
16
143
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
137
1163
1.18
1.13
3.0
3.2
u/ml
86.2
764.0
1.96
127
1058
(3045683) HLA typing for celiac disease panel - Blood or Tissue
26
176
1.48
1.10
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
29
202
1.44
1.07
3.0
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1277
13353
0.94
1.06
3.2
3.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
194
1.45
1.06
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
40
296
1.35
1.05
2.2
2.1
ug/min
61.2
206.9
—
6
80
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
34
2.06
1.02
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
692
6497
1.07
1.01
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
256
1.37
1.00
2.5
2.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1191
12445
0.95
0.97
3.0
3.2
ug/l
0.7
0.8
2.79
853
8893
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
283
0.67
0.96
1.9
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
235
0.64
0.95
1.3
1.5
—
—
—
0
0
(3025315) Body weight
7
37
1.89
0.94
5.3
4.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
101
1.59
0.93
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
588
0.78
0.91
1.6
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
75
618
1.22
0.90
1.5
1.3
nmol/l
12.2
0.7
0.49
69
589
(3016018) Differential panel - Cerebral spinal fluid
55
438
1.26
0.89
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
145
1266
1.15
0.89
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
104
0.48
0.88
2.0
5.7
—
—
—
0
0
(4034850)
173
1532
1.13
0.87
13.0
11.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
62
503
1.24
0.87
1.9
1.9
g/24h
0.6
1.0
—
5
20
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
216
0.65
0.85
1.4
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
75
623
1.21
0.84
1.5
1.3
nmol/l
0.2
0.3
—
8
45
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
34
256
1.33
0.84
1.1
1.1
mg/l
279.0
295.5
0.25
29
219
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
110
949
1.16
0.81
1.1
1.2
mmol/l
3.8
3.9
0.39
101
879
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
58
1.73
0.79
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
58
1.73
0.79
1.7
1.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
175
0.63
0.78
1.4
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
82
1.59
0.78
1.1
1.1
u/ml
1.2
52.9
—
8
35
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
225
1.34
0.77
1.4
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
127
1443
0.88
0.75
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
35
270
1.30
0.75
1.2
1.1
mg/l
51.0
44.4
0.32
28
221
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
197
1783
1.11
0.72
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
241
2204
1.10
0.72
2.4
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
123
1083
1.14
0.71
1.2
1.3
mg/l
740.2
547.8
0.40
112
1017
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
77
654
1.18
0.71
3.2
3.8
u/ml
27.6
32.1
0.33
72
633
(3025130) Human papilloma virus identified in Specimen
36
284
1.27
0.67
1.9
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
168
0.65
0.67
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.8
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
167
0.66
0.65
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
78
1.54
0.65
2.1
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
224
1.30
0.64
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
146
1.37
0.63
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
644
0.84
0.63
3.3
4.4
umol/l
325.2
346.3
0.45
42
547
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
63
1.59
0.61
1.7
2.7
u/field
0.4
0.3
—
10
63
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
64
544
1.18
0.61
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
23
301
0.76
0.60
1.2
1.4
u/l
24.7
30.8
0.60
18
246
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
272.7
—
0
20
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
418
1.20
0.58
2.2
1.8
—
—
—
0
0
(4281824)
36
442
0.81
0.57
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
185
1.30
0.56
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
293
1.23
0.55
1.8
1.4
nmol/l
0.2
0.3
1.98
27
218
(3027008) Opiates [Presence] in Urine
63
542
1.16
0.54
2.0
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
63
544
1.16
0.52
2.0
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
241
1.25
0.52
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
89
789
1.13
0.52
3.6
2.4
mmol/l
4.1
4.1
0.18
89
779
(3035285) Chloride [Moles/volume] in Venous blood
89
789
1.13
0.52
3.6
2.4
mmol/l
105.3
105.7
0.25
89
779
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
152
1.32
0.52
1.1
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
109
1.38
0.50
1.7
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
30
243
1.24
0.49
3.7
6.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
189
1.27
0.49
1.0
1.1
u/l
1.1
1.1
0.91
15
99
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
144
0.69
0.49
1.6
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
87
774
1.13
0.49
3.7
2.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
45
1.56
0.48
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
272
2555
1.07
0.48
2.9
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
94
842
1.12
0.47
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
58
503
1.15
0.47
2.1
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
550
1.15
0.47
1.5
1.3
nmol/l
—
—
—
0
0
(3019225) pH of Specimen
571
5481
1.05
0.47
5.2
4.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
61
533
1.15
0.45
1.9
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
102
922
1.11
0.45
1.2
1.4
e6/l
84.5
966.0
3.73
78
756
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
56
487
1.15
0.45
1.8
2.1
u/field
1.7
1.7
0.01
28
175
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
86
770
1.12
0.45
2.0
1.9
pmol/l
201.6
200.4
0.04
76
716
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
223
2088
1.07
0.44
1.4
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
65
572
1.14
0.44
1.2
1.3
pmol/l
282.5
261.1
0.17
51
427
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
69
1.45
0.44
2.2
2.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
69
1.45
0.44
2.2
2.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
340
1.18
0.43
3.5
5.0
u/ml
91.8
59.9
0.23
11
94
(3036525) Urea [Moles/time] in 24 hour Urine
5
32
1.56
0.42
2.4
3.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
7.8
—
0
15
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
61
539
1.13
0.40
2.0
1.9
—
—
—
0
0
(4198724)
12
88
1.36
0.40
1.2
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
354
3380
1.05
0.39
4.2
3.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
44
381
1.16
0.39
1.6
2.0
ug/l
1.6
2.1
1.17
38
317
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
101
922
1.10
0.39
1.2
1.4
e6/l
18.7
21.3
0.08
69
721
(40761535) Cells panel - Urine sediment
465
4470
1.04
0.38
4.5
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
170
1.24
0.37
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
152
1.25
0.37
20.7
16.4
nmol/l
1407.7
1426.4
0.04
19
147
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4509
44814
1.03
0.36
5.3
5.1
mmol/l
6.1
6.1
0.47
4053
39988
(3006462) Nitrate [Presence] in Urine
30
254
1.18
0.35
4.9
4.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
117
1.28
0.35
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
108
1169
0.92
0.34
3.1
2.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
82
1.34
0.34
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
154
1.23
0.33
1.8
1.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
45
1.33
0.33
1.0
1.2
u/l
7.8
11.6
—
6
45
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
46
1.30
0.33
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
94
866
1.09
0.32
1.5
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
45
398
1.13
0.32
1.3
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
107
1153
0.93
0.31
6.5
3.8
mg/l
28.4
29.8
0.17
80
751
(4211845)
32
277
1.16
0.30
4.7
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4545
45678
0.98
0.29
5.4
5.3
mmol/l
2.5
2.6
9.93
4067
41213
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
68
621
1.10
0.29
1.7
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
130
1.23
0.28
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
169
1601
1.06
0.28
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
18
149
1.21
0.27
1.7
2.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
17
140
1.21
0.27
1.6
1.4
pmol/l
17.9
16.6
—
10
110
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
118
0.76
0.27
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
41
366
1.12
0.26
2.9
3.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
2.5
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
291
1.13
0.26
2.4
2.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4427
44478
0.98
0.25
4.9
4.7
mmol/l
4.4
4.5
6.07
3962
40336
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
114
1.23
0.25
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4385
44057
0.98
0.25
4.8
4.7
mmol/l
1.4
1.4
3.82
3896
39647
(3020874) Milk IgE Ab [Units/volume] in Serum
16
133
1.20
0.24
1.0
1.1
u/ml
0.8
2.3
—
8
44
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
44
398
1.11
0.24
1.1
1.1
—
27.8
—
0
7
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
169
0.83
0.23
1.4
2.1
e6/l
1716.2
19916.0
—
5
103
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
52
475
1.10
0.23
1.2
1.2
mmol/l
7.3
7.6
0.35
36
340
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
125
1.20
0.22
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
70
651
1.08
0.22
1.1
1.1
iu/ml
73.1
65.7
0.04
16
133
(4094501)
119
1255
0.95
0.22
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
2.2
2.1
umol/l
15.6
18.1
—
5
42
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
42
1.19
0.21
1.2
4.3
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
11
0.00
0.21
0.0
6.9
—
45.3
—
0
11
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.8
—
0
6
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
2.2
—
0
12
(4133840)
8
101
0.79
0.21
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
126
1.19
0.21
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
17
145
1.17
0.20
1.5
1.7
g/l
12.6
14.7
0.38
12
114
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
420
4307
0.97
0.20
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
117
1.20
0.20
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
66
615
1.07
0.20
1.3
1.4
mu/l
51.2
59.1
0.21
58
534
(3027035) Albumin [Mass/time] in 24 hour Urine
6
48
1.25
0.20
1.8
1.3
—
640.5
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
49
1.22
0.20
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
115
0.78
0.20
1.1
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
52
1.15
0.19
14.7
10.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
268
0.90
0.17
1.5
1.4
pmol/l
60.2
165.2
—
9
86
(3051593) INR in Capillary blood by Coagulation assay
29
320
0.91
0.17
6.8
12.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
17
148
1.15
0.16
17.3
11.4
nmol/l
888.6
824.0
0.22
17
138
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
98
0.82
0.13
1.5
1.5
ng/l
183.9
159.3
—
8
98
(3037556) Urate [Mass/volume] in Serum or Plasma
19
170
1.12
0.13
1.2
1.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
17
190
0.89
0.13
2.0
2.2
umol/l
65.7
55.6
0.38
11
151
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
190
0.89
0.13
1.9
2.3
e6/l
326.0
4758.6
—
10
138
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2180
21926
0.99
0.12
4.8
5.4
ug/l
3.6
4.0
0.22
1888
19451
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
25
229
1.09
0.12
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
95
914
1.04
0.12
1.9
1.5
nmol/l
1.1
0.8
1.89
76
754
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
239
1.09
0.12
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
12
137
0.88
0.12
2.0
2.2
ug/l
1.3
1.3
0.01
12
129
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
188
1834
1.03
0.11
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
20
219
0.91
0.11
1.4
1.3
mmol/l
6.1
6.1
0.07
20
205
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
228
0.92
0.10
1.1
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
116
1.12
0.09
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
37
350
1.06
0.09
1.1
1.1
—
—
—
0
0
(4212803)
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
56
1.07
0.08
1.3
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3682
36728
1.01
0.08
41.1
22.2
g/l
329.3
331.8
50.58
3656
36353
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
176
1793
0.98
0.07
3.3
3.8
u/ml
60.7
74.6
0.35
171
1719
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
2.5
2.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
98
1.12
0.07
1.5
1.2
umol/24h
0.8
0.7
—
5
50
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
317
0.95
0.07
1.1
1.2
mmol/l
13.9
11.7
0.60
15
97
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
72
743
0.97
0.07
1.6
1.5
pmol/l
168.2
233.9
0.68
72
720
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
115
1124
1.02
0.07
2.0
1.7
mg/l
28.3
3.5
6.49
99
802
(3000034) Microalbumin [Mass/volume] in Urine
52
501
1.04
0.07
2.3
3.2
mg/l
63.4
47.0
0.25
41
385
(3002619) Bacteria identified in Specimen by Culture
8
91
0.88
0.06
1.5
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4268
42614
1.01
0.06
4.3
4.2
mmol/l
1.3
1.3
7.72
3771
37977
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
121
0.91
0.06
1.0
1.1
—
—
—
0
0
(4024509)
57
553
1.03
0.05
1.6
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
12
131
0.92
0.05
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
354
0.96
0.05
10.3
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
110
1080
1.02
0.05
1.6
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
28
293
0.96
0.05
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
101
1.09
0.04
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
141
1394
1.01
0.03
2.6
2.3
ug/min
130.0
103.2
0.37
86
812
(3033799) Differential panel - Peritoneal fluid
18
171
1.05
0.03
2.2
1.9
—
—
—
0
0
(4146454)
65
638
1.02
0.03
2.4
2.8
—
—
—
0
0
(44806420)
19
199
0.95
0.03
2.0
2.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
132
1.06
0.02
2.0
2.2
mmol/l
7.6
8.1
—
9
82
(3006270) Folate [Moles/volume] in Blood
47
478
0.98
0.01
1.1
1.2
nmol/l
295.2
337.6
0.70
36
379
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
204
1.03
0.00
1.2
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
124
0.97
0.00
1.0
1.1
u/ml
0.6
2.8
—
5
36
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
103
0.97
0.00
1.9
3.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
93
934
1.00
0.00
1.8
1.7
iu/l
4.8
4.8
0.00
26
292
(3024869) Neuronal Ab [Presence] in Serum
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
67
0.90
0.00
1.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(3044336) Cobalt [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
16.6
—
0
5
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
40.0
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
94
0.96
0.00
1.2
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2864.4
—
0
9
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.3
—
0
5
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
50
1.00
0.00
2.2
1.1
umol/24h
1.9
1.8
—
5
50
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
1364.4
—
0
9
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ILD_ENDPOINTS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ILD_ENDPOINTS | 3.129 [2.83, 3.46] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.654 |
During the follow-up period (1.1.1998 — 31.12.2019), 5154 out of 10663 females with ILD_ENDPOINTS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ILD_ENDPOINTS | 3.447 [3.02, 3.93] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 7550 out of 13773 males with ILD_ENDPOINTS died.
Mortality risk
Mortality risk for people of age
years, who have ILD_ENDPOINTS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.278% | 0.578% |
| 5 | 2.021% | 3.367% |
| 10 | 5.217% | 8.484% |
| 15 | 9.234% | 15.625% |
| 20 | 16.058% | 25.4% |
Relationships between endpoints
↥Index endpoint: ILD_ENDPOINTS – Interstitial lung disease endpoints
GWS hits: 15
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data